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 Insulin secretion by pancreatic islet β-cells is critical for glucose homeostasis, and 
a blunted β-cell secretory response is an early deficit in type 2 diabetes. While considerable 
attention has focused on mechanisms controlling β-cell mass, less is known about factors 
governing β-cell secretory responses. Here, we uncover a regulatory mechanism by which 
glucose recruits vascular-derived neurotrophins to control insulin secretion. Nerve Growth 
Factor (NGF), a classical trophic factor for nerve cells, is expressed in pancreatic 
vasculature while its TrkA receptor is localized to islet β-cells. High glucose rapidly 
enhances NGF secretion and TrkA phosphorylation in islets. Vascular-specific deletion of 
NGF, pancreas-specific TrkA deletion, or acute disruption of TrkA activity impairs glucose 
tolerance and insulin secretion in mice. Furthermore, we show that high glucose activates 
TrkA and NGF potentiates insulin secretion in human islets, and these effects are blunted 
in islets from pre-diabetic individuals. We find that internalized TrkA receptors promote 
insulin granule exocytosis via F-actin reorganization. These results reveal a non-neuronal 
role for neurotrophins, and identify a new regulatory pathway in insulin secretion that can 
be targeted to ameliorate β-cell dysfunction.  
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the bench and I am forever thankful for all of his help.  
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 Insulin-producing β-cells are a small population of endocrine cells that comprise 
less than 2% of the pancreas, yet their function is imperative to the maintenance of blood 
glucose homeostasis. In response to elevated blood glucose levels, β-cells secrete the 
hormone insulin, which triggers glucose uptake by peripheral tissues. Blunted insulin 
secretion by β-cells is one of the earliest features of type 2 diabetes, a disease affecting 
almost 300 million people worldwide (Guariguata et al., 2014), observed even in pre-
diabetic individuals and thought to precede the onset of overt hyperglycemia (Weir and 
Bonner-Weir, 2004). Strikingly, it has been postulated that by the time a diagnosis of 
diabetes is made, patients have lost almost 80% of β-cell function (Defronzo, 2009). 
Although the loss of β-cell secretory responses precedes a reduction in β-cell mass during 
the development of type 2 diabetes (Defronzo, 2009, Weir and Bonner-Weir, 2004), 
research has predominantly focused on mechanisms governing β-cell proliferation (Vetere 
et al., 2014, Wang et al., 2015, Stewart et al., 2015).  
 While glucose is the primary stimulus for insulin secretion, the β-cell secretory 
response is potentiated by extrinsic signals that include fatty acids and amino acids, peptide 
hormones, and neurotransmitters that play essential roles in the process (Henquin et al., 
2003, Prentki et al., 2013, Rorsman and Braun, 2013, Caicedo, 2013, Campbell and 
Drucker, 2013). Glucose-stimulated insulin secretion (GSIS) involves the key steps of; (1) 
glucose uptake in β-cells, (2) mitochondrial metabolism to alter the ATP/ADP ratio, (3) 
closure of ATP-sensitive K+-channels and subsequent β-cell plasma-membrane 
depolarization, (4) the opening of voltage-gated Ca2+-channels, and (5) Ca2+-dependent 
exocytosis of insulin granules (MacDonald et al., 2005). Extrinsic signals influence GSIS 
either by producing metabolic intermediates within β-cells, or by generating signaling 
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second messengers that impinge on β-cell electrical activity and/or insulin exocytosis 
(Prentki et al., 2013, Rorsman and Braun, 2013). Because the nutrient, hormonal, and 
neural inputs are precisely regulated by glucose itself, together they ensure that insulin 
secretion remains glucose-dependent at much lower plasma glucose concentrations than 
are effective in vitro (Henquin et al., 2003). Thus, a small post-prandial increase in plasma 
glucose elicits a larger insulin response than predicted from in vitro dose-response curves, 
due to interactions between glucose and non-glucose stimuli. Conversely, the exquisite 
glucose-dependence of these non-glucose insulin secretagogues is also a necessary 
protection against hypoglycemia (Henquin et al., 2003).  
 Neurotrophins are soluble peptide factors known predominantly for their functions 
in neuronal survival, axon growth, and synaptic communication in the vertebrate nervous 
system (Huang and Reichardt, 2001a). Although neurotrophins and their Trk receptor 
tyrosine kinases are expressed in non-neuronal tissues including the pancreas (Tessarollo, 
1998), little is known about their in vivo functions outside of the nervous system. Based on 
cell culture studies, autocrine signaling by the classical neurotrophin, Nerve Growth Factor 
(NGF), has been implicated in β-cell survival and secretory function (Rosenbaum et al., 
2001, Navarro-Tableros et al., 2004). However, physiological roles for neurotrophin 
signaling within pancreatic endocrine cells remain undefined. The need to understand the 
physiological relevance of neurotrophins in islet function is underscored by evidence in 
humans that altered neurotrophin secretion and/or signaling could contribute to the etiology 
of diabetes (Pittenger and Vinik, 2003, Schreiber et al., 2005, Bullo et al., 2007, Kim et al., 
2009). In humans, mutations in the TrkA gene encoding for the NGF receptor, cause a form 
of hereditary peripheral neuropathy called congenital insensitivity to pain and anhidrosis 
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(CIPA) (Indo et al., 1996). Children with CIPA show decreased insulin secretion in 
response to a glucose challenge, suggesting that NGF signaling may play a role in insulin 
responses in humans (Schreiber et al., 2005). Furthermore, altered circulating NGF levels 
have been noted in type 2 diabetes (Bullo et al., 2007, Kim et al., 2009), although whether 
this reflects a cause or effect in disease pathogenesis remains undefined. 
 Here, we uncover a fundamental role for neurotrophin signaling in controlling 
glucose-stimulated insulin secretion, and elucidate the cellular underpinnings. We found 
that NGF is robustly expressed in pancreatic vascular contractile cells, whereas its TrkA 
receptor is localized to islet β-cells. Elevated glucose rapidly increased NGF secretion and 
stimulated TrkA phosphorylation in isolated islets. Pancreas-specific TrkA deletion as well 
as acutely inactivating TrkA signaling, using a chemical-genetic approach, impaired 
glucose tolerance and reduced insulin secretion in mice. TrkA activity promotes insulin 
granule localization to the β-cell plasma membrane via disassembly of a rigid F-actin 
barrier. Furthermore, Trk-mediated endosomal signaling, a critical determinant of 
neurotrophin actions in neurons, is conserved and functionally important in pancreatic β-
cells, since endocytosis-deficient TrkA receptors were incapable of mediating actin 
remodeling and insulin secretion. These findings elucidate a new pathway by which 
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 The presence of neurotrophins and their cognate Trk receptors in the pancreas has 
been well established for several decades, (Kanaka-Gantenbein et al., 1995b, Miralles et 
al., 1998, Shibayama and Koizumi, 1996) however, their precise cellular localization 
within this complex organ has remained elusive due to notoriously unreliable antibodies 
for immunostaining and lack of expression reporter systems. Given the multitude of cell 
types found in the pancreas: acinar and ductal cells, five different endocrine cell types, 
vascular cells, enteric neurons and innervating fibers of the sensory and autonomic nervous 
system, glial cells, and immune cells, identifying the sources of both ligand and receptor 
are important for determining how neurotrophin signaling occurs in this organ. Previous 
studies have suggested that insulin-secreting β-cells express NGF that functions in an 
autocrine manner (Vidaltamayo et al., 2003, Rosenbaum et al., 1998). However, these 
experiments were limited to in vitro analyses of dissociated islets, and expression of NGF 
could therefore be an artifact of cell culture conditions. 
 Early studies performed in the developing rat pancreas also indicate that all 
pancreatic cell types express TrkA at embryonic day 12; however, by adulthood, this 
expression is reduced and restricted to endocrine cells (Miralles et al., 1998). Despite these 
findings, there is contention in the literature regarding the identity of the pancreatic and 
specifically the endocrine cell types that continue to express TrkA in the adult (Teitelman 
et al., 1998). Additional studies have investigated the expression of other neurotrophin 
receptors in the pancreas and found that glucagon-secreting alpha cells express the high 
affinity BDNF receptor, TrkB (Hanyu et al., 2003). In this study, we use a combination of 
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ligand binding and an NGF reporter mouse to definitively show which pancreatic cell types 


























 We first confirmed expression of TrkA and NGF in both the embryonic pancreas 
and adult islets using RT-PCR. While levels of NGF and TrkA appear to be reduced in 
adult islets compared to embryonic pancreas, samples from adult islets are enriched for 
endocrine cells at the expense of other cell types including ductal cells and vasculature 
(Fig. 1-1).  
 It has long been held that NGF is expressed in limiting quantities by tissues that are 
innervated by the peripheral nervous system (Cohen and Levi-Montalcini, 1956, 
Deppmann et al., 2008). β-cells are richly innervated by the autonomic nervous system 
(Rodriguez-Diaz et al., 2011), and have been reported to express NGF by RT PCR and 
western blot analysis (Pierucci et al., 2001, Rosenbaum et al., 1998). We find that 
NGFLacZ/+ reporter mice show strong X-gal staining in vascular structures (Fig. 1-2A). 
Additional immunohistochemical analysis with antibodies against SMA and PDGFRβ 
show that NGF is primarily expressed in smooth muscle cells and intra-islet pericytes 
respectively (Fig. 1-2B,C). No reporter expression is detected in pancreatic ducts or 
endothelial cells of the intra-islet vasculature (Fig. 1-3A,B) These results do not rule out 
any production of NGF by β-cells as previously reported (Rosenbaum et al., 1998), and 
indeed we see beta-galactosidase activity in dissociated β-cells from NGFLacZ/+ mice in 
culture (Fig. 1-3C,D). In dissociated islet cultures, we found most of the NGF labeling to 
be in intra-islet pericytes (Fig. 1-3E and 1-3E’). Together, these results suggest that 
vascular contractile cells are the likely source of NGF in the pancreas. 
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 In order to determine which cell types in the pancreas express NGF receptors, we 
performed ligand binding with biotinylated NGF (200ng/mL). I found the highest 
concentration of binding occurred within islets, and colocalized with insulin (Fig 1-4A). 
Although NGF binds with high affinity to TrkA receptors, β-cells are also known to express 
the low affinity neurotrophin receptor, p75 which could contribute to the observed NGF 
ligand-binding signal in the pancreas (Pierucci et al., 2001, Raile et al., 2006). However, 
immunostaining for p75 reveals distinctly neuronal expression of p75 with no significant 
signal observable within islets (Fig. 1-4B), indicating that the primary source of TrkA 

















Figure 1-1: NGF and TrkA expression in the pancreas  
RT-PCR analysis of NGF and TrkA expression in E15 pancreas and islets isolated from 1 
month old wildtype mice. NGF and TrkA expression appear to be reduced in adult islets 














Figure 1-2: NGF is expressed in pancreatic vascular contractile cells 
(A) X-gal staining reports prominent NGF expression in large diameter blood vessels (red 
arrows) outside islets, and also within islets (red arrowheads) in tissue sections from 
NGFLacZ/+ mice. An islet is outlined in dashed lines, and shown in higher magnification in 
the right panel. Scale bar, 100 µm (B,C) Immunostaining shows co-localization of β-
galactosidase (red) with smooth muscle actin (SMA, green) in large blood vessels, and with 
PDGFRβ (green), a pericyte marker, in the intra-islet microvasculature. Insulin staining is 
shown in blue. (C’) shows a higher magnification image of (C). Scale bars, 100 µm for (C) 













Figure 1-3: NGF is undetectable in endothelial and ductal cells, and lowly expressed 
in cultured β-cells  
(A,B) Immunostaining for β-galactosidase that reports NGF expression shows little co-
localization with endothelial cells, stained with PECAM, or pancreatic ducts, labeled with 
DBA, in tissue sections from NGFLacZ/+ mice. Islets are marked by insulin immunostaining. 
Scale bar, 50 μm. (C,D) Single dissociated NGFLacZ/+ β-cells in culture show low 
expression of β-galactosidase compared with control NGF+/+ β-cells. β-cells were 
identified by co-labeling with insulin. Representative images are shown from at least 3 
animals per genotype that were analyzed. Scale bar, 5 μm. (E) In dissociated islet cultures, 
β-galactosidase immunostaining shows NGF expression predominantly in pericytes. 
Arrowheads indicate a few isolated β- cells NGF expression. The pericytes and β-cells are 
marked by PDGFRβ and insulin immunostaining respectively. (E’) shows a higher 







Figure 1-4: Neurotrophin receptors are expressed in the adult pancreas 
(A) Biotinylated NGF binding is detected in insulin-positive β-cells in pancreatic tissue 
sections. (B) p75 immunostaining shows expression in fibers innervating the islet 














 Islets are a major target of sympathetic innervation in the pancreas, and there are 
several lines of evidence to support the belief that β-cells provide NGF to innervating 
nerves (Rosenbaum et al., 1998, Vidaltamayo et al., 2003). This led to a model where 
neurotrophin signaling in islets occurs in an autocrine fashion, in which β-cells secrete 
NGF to activate TrkA receptors on the cell surface. In contrast to this view, we have found 
that pancreatic contractile cells of the pancreatic vasculature predominantly contribute to 
NGF expression in the pancreas. Smooth muscle cells that ensheath large diameter blood 
vessels express the highest levels of NGF broadly across the pancreas, while intra-islet 
pericytes contribute to local NGF levels within islets. Loss of endothelial cells in the adult 
pancreas has little influence on islet function or glucose tolerance(Reinert et al., 2013), but 
there has been no thorough investigation of the role of other vascular cell types such as 
smooth muscle cells and pericytes play in islet biology. Our observations of the spatial 
pattern of NGF and TrkA expression in the pancreas are most consistent with a paracrine 
effect of vascular-derived NGF on neighboring β-cells. 
 Using biotinylated NGF, we were able to detect binding in sections of adult 
pancreas, specifically within β-cells in the islets of Langerhans. These results agree with 
previous findings indicating that TrkA expression in the pancreas is restricted to islets in 
adulthood. However, other studies suggest TrkA expression in several exocrine pancreatic 
cell types during development (Miralles et al., 1998, Kanaka-Gantenbein et al., 1995a). 
Thus, a comprehensive time-course analyzing TrkA expression in the pancreas would 
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significantly augment our current understanding of when and where TrkA signaling is 


























All procedures relating to animal care and treatment conformed to Johns Hopkins 
University Animal Care and Use Committee (ACUC) and NIH guidelines. Mice were 
housed in a standard 12:12 light-dark cycle. Mice were maintained on a C57BL/6 
background, or mixed C57BL/6 and 129P, or C57BL/6 and FVB backgrounds. Both sexes 
were used for analyses at 1-2 months of age, unless stated otherwise in the figure legends. 
NGFLacZ/+ mice were a generous gift from Dr. David Ginty (Harvard).  
 
Antibodies 
Primary antibodies for immunofluorescence include guinea pig anti-insulin (1:300, abcam 
ab7842), rabbit anti-p75 (1:200, Promega G323A), chicken anti-beta-galactosidase (1:100, 
Millipore AB3403-I), rat anti-PECAM (CD31) (1:200, BD Biosciences 550274), FITC-
mouse-anti-SMA (1:500, Sigma F3777), and rabbit anti-PDGFRβ (1:100, abcam 
ab32570). Fluorescent secondary antibodies were Alexafluor-350, -488,-546, or -647-
conjugated and used at 1:200 (Invitrogen)  
 
X-gal staining, immunohistochemistry, and islet morphology  
Pancreatic NGF receptors were labeled by incubating 10µm thick mouse tissue sections 
with biotinylated NGF (200 ng/ml) for 1 hour at room temperature. Biotinylated NGF was 
prepared according to the manufacturer’s instructions using EZ-LinkTM Micro Sulfo-NHS-
Biotinylation kit (ThermoFisher Scientific, 21925). Following incubation with biotinylated 
NGF, tissue sections were washed and immunostained for insulin as described below. 
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Biotinylated NGF was detected using Alexa-546-conjugated streptavidin (1:200, 
Invitrogen, S11225). Sections were imaged using a Zeiss AxioImager M1 microscope 
equipped with an Axiocam HRc camera.  
 
For X-gal staining, pancreata from NGFLacZ/+ mice were fixed in 0.2% glutaraldehyde and 
2mM MgCl2 in PBS overnight at 4ºC. Tissues were equilibrated in 30% sucrose and 
embedded in OCT. 10 µm-thick sections were collected and stained with a solution 
containing X-gal (1 mg/ml, Invitrogen), 5mM K3Fe(CN)6, 5mM K4Fe(CN)6, 2mM MgCl2, 
0.1M NaPO4, 0.01% sodium deoxycholate, and 0.02% NP40.  
 
For immunofluorescence, tissues were fixed overnight in 4% paraformaldehyde (PFA) 
(Sigma) at 4oC, cryoprotected in 30% sucrose overnight, frozen in OCT, and 10µm thick 
sections were collected. Sections were permeabilized in PBS with 1% Triton X-100, 
blocked in 5% goat serum with 0.1% Triton X-100 in PBS, and incubated in blocking 
solution containing primary antibodies overnight at 4ºC. Sections were then washed with 
PBS and incubated with secondary antibodies diluted in blocking solution for 1 hour at 
room temperature. Ductal epithelium was detected using rhodamine-labeled Dolichos 
Biflorus Agglutinin (DBA) (1:200, Vector Laboratories RL-1032) applied during 
secondary antibody incubation. Sections were washed in PBS and mounted in Fluoromount 
Aqueous Mounting Medium (Sigma Aldrich, F4680) containing 100μg/ml DAPI. Images 
representing 1μm optical slices were taken using a Zeiss LSM 700 confocal microscope 




For morphometric analyses of islets, 10μm thick sections of pancreata were collected every 
200μm covering the entire pancreas, immunostained for insulin and glucagon, and imaged 
on a Zeiss AxioImager. Islet areas were determined using the ImageJ software (NIH). 
 
Islet isolation, and RT-PCR analysis 
Islets were isolated as previously described (Wollheim et al., 1990). Briefly, pancreata 
collected from 1-2 month old mice were distended using collagenase (Collagenase P, 0.375 
mg/ml, Roche) dissolved in Hank’s Balanced Salt Solution (HBSS, Mediatech), and 
digested at 37°C. Digested pancreata were washed with HBSS, and subjected to 
discontinuous density gradient centrifugation using varying histopaque densities (Sigma-
Aldrich). The islet layer was collected, washed with HBSS, and islets handpicked under an 
inverted microscope. 
 
Islets from 1-2 month old mice or the total pancreas from embryonic day 15 mice were 
collected, lysed in Trizol reagent (Invitrogen), and RNA purified using RNeasy micro 
columns (Qiagen). RNA was then reverse transcribed using a RETROscript kit (Ambion), 
and RT PCR was carried out using the primers TrkA-Fwd: 5’-
TCCAAGTCAGCGTCTCCTTCCCA, TrkA-Rev: 5’-
AGCCGTTGAACAACCAGCGCA, NGF-Fwd: 5’-GGGAGCGCATCGAGTTTTG, 
NGF-Rev: 5’-CACCTCCTTGCCCTTGATGT, S18-Fwd: 5'-














Portions of this chapter were previously submitted for publication at Developmental Cell:  
Jessica Houtz, Philip Borden, Alexis Ceasrine, and Rejji Kuruvilla (2016). Neurotrophin 
















NGF and TrkA in the pancreas  
 NGF has previously been proposed to directly influence β-cell development and 
function. Early studies found that application of NGF to fetal β-cells or β-cell lines led to 
the extension of neurite-like processes, increased biosynthesis of insulin, and increased 
production of the neurotransmitter, GABA (Polak et al., 1993, Vidaltamayo et al., 1996, 
Gonzalez del Pliego et al., 2001, Navarro-Tableros et al., 2004). Work performed in single 
dissociated rat β-cells has further demonstrated that NGF is capable of eliciting an increase 
in glucose stimulated insulin secretion and Ca2+ currents (Rosenbaum et al., 2001, 
Rosenbaum et al., 2002, Frodin et al., 1995). 
 Similar to its key role in neuronal development, NGF has also been implicated in 
β-cell survival. NGF depletion using a neutralizing antibody was shown to result in 
inhibition of PI3K signaling and activation of c-Jun kinase and subsequent apoptosis in 
both human islets and a β-cell line (Pierucci et al., 2001). In another investigation, 
induction of β-cell death with streptozotocin was somewhat diminished by the application 
of 4-methylcatechol which stimulates NGF production (Gezginci-Oktayoglu and Bolkent, 
2011).  
 Although some studies indicate that the source of NGF in the pancreas may be 
supplied by non-endocrine cells surrounding β-cells (Miralles et al., 1998, Kanaka-
Gantenbein et al., 1995a), other bodies of work have demonstrated that NGF could be 
produced by β-cells themselves in vitro (Hiriart et al., 2001, Rosenbaum et al., 1998), 
implying an autocrine signaling mechanism. It is possible that, under culture conditions, 
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dissociated β-cells are stimulated to produce limited amounts of NGF, but there has been 
very little analysis of regulated NGF secretion in vivo. Interestingly, a study comparing the 
regulation of TrkA and p75 in islets versus a β-cell line found that glucose elicits opposite 
effects on neurotrophin receptor expression in the different systems. In the Ins1 β-cell line, 
TrkA expression decreases with increasing concentrations of glucose in culture, whereas, 
glucose has a stimulatory effect on islet expression of neurotrophin receptors and Ins1 
expression of p75 (Raile et al., 2006). In this study we define a previously unrecognized 
role for paracrine NGF signaling from intra-islet pericytes and vascular smooth muscle 
cells in large diameter blood vessels in regulating insulin secretion from islets. 
 
Neuron-target interactions during development 
 The effects of neurotrophin signaling have been best studied in the developing 
nervous system where they have been shown to influence neuron proliferation and survival, 
axon growth and branching, and synaptic plasticity (Huang and Reichardt, 2001a, Chao et 
al., 2006). The timing of neurotrophin dependent development of neurons often coincides 
with critical developmental time points in non-neuronal systems, and there is mounting 
evidence that neurons participate in the development of the tissues they innervate. A classic 
example of this neuron-target interaction is the development of the neuromuscular junction 
(Sanes and Lichtman, 1999). More recently, studies have established additional roles for 
peripheral innervation in mediating the development of a variety of targets including the 
salivary glands (Knox et al., 2010, Nedvetsky et al., 2014), bone (Fukuda et al., 2013), and 
immune system (Tian et al., 2011). In a recently published study, we identified sympathetic 
signaling through beta-adrenergic receptors as a key regulator of pancreatic islet 
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architecture during development and β-cell function (Borden et al., 2013). We employed a 
genetic approach to delete TrkA specifically in neurons, accomplished by crossing mice 
expressing Cre recombinase under the control of the tyrosine hydroxylase promotor (TH-
Cre) with conditional, floxed TrkA mice. The resulting TH-Cre;TrkAf/f mice have no or 
vastly attenuated sympathetic innervation of peripheral tissues, including the pancreas. We 
found that these mice have pancreatic islets with severe disruptions in islet architecture and 
impaired glucose tolerance and insulin secretion. However, since TH-Cre;TrkAf/f mice also 
exhibit a loss of sensory neurons that briefly express TH during development and rely on 
TrkA signaling for survival, my contribution to this study (detailed in the Results section 
below) was to use a chemical sympathectomy approach to elucidate the role of sympathetic 

















Neurotrophin signaling directly affects adult islet function 
 Given our expression analysis in NGFLacZ/+ mice (see Chapter 1, Fig. 1-2) we 
hypothesized that NGF coming from smooth muscle contractile cells, and not β-cells 
themselves, might be contributing to neurotrophin signaling in the adult. To this end we 
employed a genetic mouse model in which we can spatially and temporally ablate NGF 
only in large diameter blood vessels and pericytes in the adult. 
 
Conditional ablation of NGF in adult vasculature impairs glucose homeostasis and insulin 
secretion 
 Previous studies have indicated that NGF positively influences adult β-cell function 
and survival (Rosenbaum et al., 2002, Pierucci et al., 2001, Hata et al., 2015). However, 
these results were obtained using in vitro methods in which exogenous NGF is added to 
cultured β-cells. Utilizing mouse genetics, we provide the first in vivo analysis of NGF 
function in the adult pancreas. In order to ablate NGF in adult smooth muscle cells, we 
crossed mice expressing a Myh11-CreER transgene, which has been shown to be 
specifically expressed in smooth muscle contractile cells and pericytes (Wirth et al., 2008, 
Joyce et al., 1985), with conditional NGFf/f mice (Muller et al., 2012). We confirmed 
expression of Myh11-CreER in the relevant vascular cells in the pancreas by co-localization 
of Myh11-CreER; reporter expression and immunostaining for β-galactosidase in 
NGFLacZ/+;Myh11-CreER (R26-YFP) double mutant mice two weeks after injection with 
tamoxifen (Fig. 2-4A,A’). Furthermore, qPCR analysis of NGF expression in isolated islets 
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from Myh11-CreER;NGFf/f conditional mice revealed a 64% reduction in tamoxifen treated 
mice compared with vehicle treated mice (Fig. 2-4B). When we evaluated metabolic 
parameters in conditional NGF mutant mice, we found that tamoxifen treated Myh11-
CreER;NGFf/f have impaired glucose tolerance and reduced insulin secretion in vivo (Fig. 
2-4C,D). In addition to whole-animal defects in glucose tolerance and insulin secretion, 
we found a similar impairment in GSIS in vitro in islets isolated from vehicle and 
tamoxifen treated Myh11-CreER;NGFf/f mice (Fig. 2-4E). 
 
Pancreatic NGF does not contribute to β-cell function 
 While our findings in tamoxifen treated Myh11-CreER;NGFf/f conditional mice 
strongly support a model in which the local source of NGF in the pancreas that is important 
for β-cell function comes from vascular smooth muscle, others have suggested that β-cells 
synthesize and secrete NGF to promote autocrine neurotrophin signaling within islets 
(Rosenbaum et al., 1998, Vidaltamayo et al., 2003). Given these previous findings, and our 
own in vitro data demonstrating expression of β-galactosidase in vitro in β-cells from 
NGFLacZ/+ reporter mice, we tested the function of NGF in the pancreas. Pdx1-Cre;NGFf/f 
were generated by crossing NGF conditional mice with mice expressing Cre recombinase 
under the control of Pdx1, a transcription factor expressed in pancreatic progenitor cells 
(Hingorani et al., 2003). Pdx1-Cre;NGFf/f mice would be expected to have an early and 
pancreas-wide deletion of NGF. However, when we performed qPCR analysis on islets 
isolated from Pdx1-Cre;NGFf/f and NGFf/f mice, we found no significant reduction in NGF 
expression (Fig. 2-5A). This result is in contrast with the reduction in islet NGF expression 
we found in Myh11-CreER;NGFf/f mice, and strongly suggests that vascular smooth muscle 
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is the relevant source of NGF in the pancreas. In further support of this notion, glucose 
tolerance is no different between Pdx1-Cre;NGFf/f and NGFf/f mice (Fig. 2-5B), confirming 
that autocrine NGF signaling does not play an important role in vivo in maintaining glucose 
homeostasis.   
 
Neurotrophin signaling indirectly influences islet biology through its effects on 
sympathetic innervation  
 While the focus of this thesis is on a direct role for neurotrophin signaling in the 
pancreas in β-cell function, I have also contributed to work that defines a role for 
sympathetic innervation in the proper development of islet architecture and function. Since 
NGF is a vial to the survival of sympathetic neurons that innervate islets, neurotrophin 
signaling can be viewed as having an indirect impact on β-cell development and function 
via its influence on pancreatic innervation. In addition to sympathetic neurons, there are a 
population of sensory neurons that transiently express TH early during development and 
also rely of TrkA for survival. We found a loss of both sensory and sympathetic innervation 
in islets from TH-Cre;TrkAf/f mice that was accompanied by alterations in islet architecture 
and impaired glucose tolerance in adulthood (Borden et al., 2013). In order to dissect which 
peripheral neurons were responsible for instructing islet formation I performed chemical 
sympathectomy using the drug 6-hydroxydopamine (6-OHDA). 6-OHDA is an isomer of 
norepinephrine that functions as a neurotoxin in sympathetic neurons where it is selectively 
taken up by the vesicular monamine transporter 2 (VMAT2). Once inside neurons, 6-
OHDA is oxidized to produce free radicals that destroy nerve terminals.  
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 Starting from birth (P0), we treated postnatal mouse pups with 6-OHDA for 6 days 
to destroy sympathetic innervation. I observed a selective loss of TH fibers innervating 
islets in postnatal day 6 (P6) mice (Fig. 2-3A,B), while CGRP expressing sensory fibers 
remained intact (Fig. 2-3C,D). Similar to the defects seen in islet architecture in TH-
Cre;TrkAf/f animals, I found irregular pancreatic islet shapes (Fig. 2-4A,B,E) and 
mislocalization of alpha cells in animals treated with 6-OHDA (Fig. 2-4C,D,F). When 
allowed to age to one month, animals injected with 6-OHDA showed normal glucose 
tolerance (Fig. 2-5). These data are in contrast with the obvious defects in glucose tolerance 
observed in TH-Cre;TrkAf/f mice, and additional analyses will be necessary to determine if 
sympathetic innervation remains absent by one month of age, after the last treatment of 6-
OHDA at P6. Reports of axon regeneration following 6-OHDA treatment suggest that the 
normal glucose tolerance I observed could be due to restoration of sympathetic innervation 
by this time. Alternative possibilities are that sensory innervation contributes to normal β-
cell function, or that sympathetic innervation is important during an early developmental 










Figure 2-1: Conditional deletion of NGF in the adult vasculature results in impaired 
glucose tolerance and insulin secretion. 
(A,A’) Expression of Myh11-CreER (R26-YFP) in NGFLacZ/+ (β-gal immunostaining) 
smooth muscle cells and intra islet pericytes scale bars, (A) 100µm, (A’) 50µm. (B) qPCR 
analysis reveals a 64% deletion of NGF in islets from Myh11-CreER;NGFf/f mice treated 
with tamoxifen (Tmxfn) compared to vehicle. Values are the mean ± SEM from n=4 
independent experiments. ∗∗p<0.01, t-test. (C) Loss of NGF in adult vasculature results in 
impaired glucose tolerance in Myh11-CreER;NGFf/f mice treated with tamoxifen. Values 
are mean ± SEM for n=7 vehicle and n=7 tmxfn injected mice. *p<0.05. (D) In vivo 
glucose-stimulated insulin secretion is attenuated by loss of NGF in Myh11-CreER;NGFf/f 
mice. Values are mean ± SEM for n=12 vehicle and n=12 tmxfn injected mice.*p<0.05, 
**p<0.01, t-test. (E) Glucose stimulated insulin secretion is attenuated in Myh11-
CreER;NGFf/f mice treated with tamoxifen compared to vehicle. Values are means ± SEM 
from n=8 Vehicle and n=8 Tmxfn treated animals. *p<0.05, **p<0.01, two-way ANOVA 







Figure 2-2: Conditional deletion of NGF in the pancreas does not influence glucose 
homeostasis 
(A) Expression of NGF in islets from Pdx1-Cre;NGFf/f mice is not reduced compared to 
NGFf/f littermates by qPCR analysis. Values are means ± SEM for n =2 NGFf/f and n=2 
Pdx1-Cre;NGFf/f difference is not significant by one-sample t-test. (B) Glucose tolerance 












Figure 2-3: 6-OHDA selectively abolishes sympathetic innervation but not sensory 
innervation of islets in postnatal day 6 mice. 
(A and B) Treatment of newborn mice with 6-OHDA daily until postnatal day 6 (P6) 
results in depletion of sympathetic fibers (arrows) in the pancreas. (C,D) Mice treated with 





Figure 2-4: Selective chemical sypathectomy with 6-OHDA results in impaired islet 
architecture 
(A, B) Chemical sympathectomy with 6-OHDA administration disrupts islet clustering in 
neonatal MIP-GFP mice. GFP+ β cells (green) and DAPI (nuclei) staining are shown. Scale 
bars, 100µm. (C,D) Immunostaining for islet hormones shows disrupted arrangement of 
endocrine cells within islets in neonatal (P6) mice treated with 6-OHDA. (E) Islet shape is 
quantified by circularity index, and (F) percentage of islets with mis-localized α cells in P6 
mice treated with 6-OHDA compared with vehicle. Values are mean ± SEM from 5 control 
and 3 mutant animals, *p<0.05, t-test. Philip Borden performed quantifications represented 








Figure 2-5: Postnatal administration of 6-OHDA does not appear to impair glucose 
tolerance in adulthood 
Mice were injected with glucose (2g/kg body weight) delivered intra-peritoneally (i.p.), 
after an overnight (16 hour) fast. Values are the mean ± SEM for n=2 vehicle and n=2 6-












 Our work defines a direct role for NGF in mediating glucose homeostasis and 
insulin secretion. Excitingly, we provide the first in vivo evidence that NGF is important 
for maintaining glucose homeostasis in the adult (Fig. 2-1). The defects in glucose 
homeostasis and insulin secretion we see in Myh11-CreER;NGFf/f mice, together with the 
NGF expression pattern (Chapter 1 Fig. 1-2 and Fig. 2-1), imply that vascular signals 
derived from large diameter blood vessels juxtaposed to islets should be sufficient to 
support adult islet function. Consistent with this notion, recent studies have shown that 
regression of intra-islet microvasculature due to loss of VEGF signaling did not perturb 
adult insulin secretion, and elicited only modest elevations in blood glucose (Reinert et al., 
2013, D'Hoker et al., 2013). While the precise role of pericytes in islet function is unclear, 
these contractile cells are known to be important for maintaining vascular stability 
throughout the body (Hellstrom et al., 2001), and a dramatic hyperplasia of intra-islet 
pericytes accompanied by thickening of the capillary basement membrane and peri-
capillary fibrosis in the pancreas is observed in models of both type 1 (Tang et al., 2013) 
and type 2 diabetes (Hayden et al., 2008, Dai et al., 2013, Nakamura et al., 1995).  Our 
results suggest that pericytes provide crucial paracrine signaling to maintain islet function, 
beyond their established role in maintaining microvascular stability. 
 Neurotrophin signaling has been best studied in the classical sense where targets 
provide trophic support to innervating neurons. Interestingly, there is growing evidence 
that reciprocal interactions occur in which neurons shape the development of their target 
tissues (Fukuda et al., 2013, Knox et al., 2010, Tian et al., 2011). We demonstrate a 
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previously unappreciated, indirect role for neurotrophin signaling in shaping islet 
architecture via sympathetic innervation. Since chemical ablation of the sympathetic 
nervous system starting at birth effectively altered islet architecture, but did not impair 
glucose tolerance in mice, it is likely that neuron-target interactions influence islet 
development at very early stages in development. These findings also raise the intriguing 
possibility that functional deficits seen in genetic sympathectomized mice are not 
necessarily a consequence of disrupted islet architecture. Future studies also investigating 
critical windows of development would be of use in determining when sympathetic 
innervation is important for different aspects of islet biology.  
 Given the significance of NGF in determining the extent of islet innervation, and 
the importance of sympathetic innervation in shaping islet development and function, it 
would be very interesting to look at the patterns of innervation in Pdx1-Cre;NGFf/f mice 
and tamoxifen-treated Myh11-CreER;NGFf/f mice at different stages of development. 
Although our data suggests that pancreas-derived NGF doesn’t play a critical role in islet 
function, pancreas-wide loss of NGF would be expected to reduce sympathetic innervation 
to acinar and ductal cell types as well, which may influence the exocrine function of the 
pancreas. Furthermore, there are reported differences in sympathetic innervation of human 
versus mouse islets (Dolensek et al., 2015, Rodriguez-Diaz et al., 2011), which may reflect 
species-specific differences in patterns of NGF expression in the pancreas. While 
sympathetic nerves in mouse islets have been shown to primarily innervate the mantle of 
islets, with most contacts being made on glucagon secreting alpha cells, there is only sparse 
innervation of endocrine cells in human islets with most contacts being made on vascular 
smooth muscle cells (Dolensek et al., 2015). It is curious that although vascular cells appear 
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to provide the greatest source of NGF in the pancreas, sympathetic neurons in mice do not 
innervate intra-islet vascular cells to the extent seen in human islets. Future studies will be 
important in determining how pancreas-specific and vascular-specific deletion of NGF 
influences innervation and morphology of the pancreas during development. It is possible 
that smooth muscle cells undergo important changes in the regulation of NGF secretion 
during development that confer differences in innervation versus paracrine signaling to β-





















All procedures relating to animal care and treatment conformed to Johns Hopkins 
University Animal Care and Use Committee (ACUC) and NIH guidelines. Mice were 
housed in a standard 12:12 light-dark cycle. Mice were maintained on a C57BL/6 
background, or mixed C57BL/6 and 129P, or C57BL/6 and FVB backgrounds. Both sexes 
were used for analyses at 1-2 months of age, unless stated otherwise in the figure legends. 
MIP-GFP (strain no: 006864) and Myh11-CreER (strain no: 019079) were obtained from 
Jackson Laboratory, and Pdx1-Cre mice (Tg(Pdx1-CreTuv) strain no: 01XL5) mice were 
obtained from NCI Frederick mouse repository. Floxed NGF (NGFf/f) mice were a 
generous gift from Dr. Liliana Minichiello (Oxford) and NGFLacZ/+ mice were a generous 
gift from Dr. David Ginty (Harvard).  
 
6-OHDA Injections 
Beginning on the day of birth (P0), TrkAf/f mice were injected i.p. once daily with 250 
mg/kg of 6-OHDA (Sigma-Aldrich) freshly dissolved in 0.1% ascorbic acid (Sigma-
Aldrich) in 0.9% saline (Sigma-Aldrich) or with ascorbic acid-saline solution as a control. 
Pups were sacrificed at P6 and pancreata processed for TH, CGRP, insulin, and glucagon 
immunofluorescence. For glucose tolerance testing, mice were aged to 1 month after the 





Beginning at 5-6 weeks of age, Myh11-CreER(R26-YFP);NGFLacZ/+ or Myh11-CreER;NGFf/f 
or mice were injected subcutaneously with 180mg/kg tamoxifen (Sigma) in corn oil, or 
corn oil alone, for 5 days. 2-3 weeks after the last injection, vehicle and tamoxifen mice 
underwent glucose tolerance and insulin secretion testing.  
 
Antibodies 
Primary antibodies for immunofluorescence include guinea pig anti-insulin (1:300, abcam 
ab7842), mouse anti-glucagon (1:400, abcam ab10988), rabbit anti-TH (1:500, 
MilliporeAB152), rabbit anti-CGRP (1:500, Sigma-Aldrich C8198), and chicken anti-beta-
galactosidase (1:100, Millipore AB3403-I). Fluorescent secondary antibodies were 
Alexafluor-350, -488,-546, or -647-conjugated and used at 1:200 (Invitrogen)  
 
Immunofluorescence  
Tissues were fixed overnight in 4% paraformaldehyde (PFA) (Sigma) at 4oC, cryoprotected 
in 30% sucrose overnight, frozen in OCT, and 10 µm thick sections were collected. 
Sections were permeabilized in PBS with 1% Triton X-100, blocked in 5% goat serum with 
0.1% Triton X-100 in PBS, and incubated in blocking solution containing primary 
antibodies overnight at 4ºC. Sections were then washed with PBS and incubated with 
secondary antibodies diluted in blocking solution for 1 hour at room temperature. Sections 
were washed in PBS and mounted in Fluoromount Aqueous Mounting Medium (Sigma 
Aldrich, F4680) containing 100μg/ml DAPI. Images representing 1μm optical slices were 
taken using a Zeiss LSM 700 confocal microscope equipped with 405, 488, 555, and 633 




Morphometric analyses of islets  
10μm thick sections of pancreata were collected every 200μm and immunofluorescently 
labeled for insulin and glucagon. Islet circularity was determined using the ImageJ software 
(NIH) shape descriptors tool, calculated by the equation: 
circularityindex=4π(area/perimeter2) with ‘1’ and ‘0’ denoting a perfect circle and an 
increasingly elongated polygon, respectively. For cytoarchitecture analyses, an islet was 
considered to have increased α-cell core localization if more than three α-cells were 
localized to greater than two cell layers inside of the outer islet perimeter.  
 
Islet isolation, and quantitative RT-PCR analysis 
Islets were isolated as previously described (Wollheim et al., 1990). Briefly, pancreata 
collected from adult mice were distended using collagenase (Collagenase P, 0.375 mg/ml, 
Roche) dissolved in Hank’s Balanced Salt Solution (HBSS, Mediatech), and digested at 
37°C. Digested pancreata were washed with HBSS, and subjected to discontinuous density 
gradient centrifugation using varying histopaque densities (Sigma-Aldrich). The islet layer 
was collected, washed with HBSS, and islets handpicked under an inverted microscope. 
 
Islets were collected, lysed in Trizol reagent (Invitrogen), and RNA purified using RNeasy 
micro columns (Qiagen). RNA was then reverse transcribed using a RETROscript kit 
(Ambion). Quantitative RT PCR was carried out using SYBR geen mix (BioRad) in an 
Applied Biosystems StepOnePlus RT PCR cycler instrument, using the primers: NGF-
Fwd: 5’-GACTCCAAACACTGGAACTCATACTG, NGF-Rev: 5’- 
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GCCTGCTTCTCATCTGTTGTCA, 18s-Fwd: 5'- CGCCGCTAGAGGTGAAATTC, 18s-
Rev: 5'- TTGGCAAATGCTTTCGCTC. Fold change in NGF transcript levels was 
calculated using the -2ΔΔCt method, normalizing to 18S rRNA transcript. 
 
In vivo analyses of glucose tolerance, and glucose induced insulin secretion 
For glucose tolerance tests, 1-2 month-old mice were fasted overnight, with a blood glucose 
reading the evening before the assay serving as a fed blood glucose measurement. The next 
morning, mice were injected with glucose (2g/kg, i.p). Blood glucose measurements were 
made from tail blood using a OneTouch Ultra glucometer at the indicated times (Gu et al., 
2010). For acute treatments with 1NMPP1, mice received i.p. injections with 20ng/g 
1NMPP1 or DMSO, 20 minutes prior to glucose administration.  
 
For in vivo insulin secretion assays, mice were fasted overnight before being injected with 
glucose (3 g/kg, i.p.). Blood was collected from the tail at the times indicated, spun down, 
and the resulting plasma fractions subjected to insulin ELISA (Crystal Chem, 90080). 
Reactions were assessed using a Tecan infinite 200 plate reader.  
 
In vitro GSIS assays 
For insulin secretion assays in isolated islets, harvested islets were allowed to recover 
overnight in RPMI 1640 media containing 5% fetal bovine serum (FBS) and 5 U/l 
penicillin/streptomycin. Islets were washed in Krebs-Ringer HEPES buffer (KRHB) 
containing low (2.8 mM) glucose and allowed to stabilize for 1 hour. Groups of 5-10 islets 
were then handpicked into 24-well dishes and further incubated in low (2.8 mM) or high 
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glucose (16.7 mM) in KRHB buffer for another 30 minutes. Supernatant fractions were 
removed, the islets were lysed in acid ethanol, followed by insulin ELISA (Crystal Chem) 



























CHAPTER 3. TRKA SIGNALING IN β-CELLS IS NECESSARY FOR GLUCOSE 




Portions of this chapter were previously submitted for publication at Developmental Cell:  
Jessica Houtz, Philip Borden, Alexis Ceasrine, and Rejji Kuruvilla (2016). Neurotrophin 
















Neurotrophin signaling in β-cells 
 A potential intrinsic role for neurotrophins in the development and function of the 
pancreas has been realized for almost 25 years, although in vivo evidence and detailed 
mechanisms have been lacking. Reports of TrkA expression have been made for a variety 
of cell types in both the exocrine and endocrine pancreas during early and adult stages of 
development (Shibayama and Koizumi, 1996, Sariola, 2001, Miralles et al., 1998, Kanaka-
Gantenbein et al., 1995b, Scharfmann et al., 1993). All studies, including our results, agree 
that β-cells express TrkA, and subsequent work has focused on the effect of NGF on β-cell 
development and insulin secretion.   
 Work performed in single dissociated rat β-cells has further demonstrated that NGF 
is capable of eliciting an increase in glucose stimulated insulin secretion and Ca2+ currents 
(Rosenbaum et al., 2001, Rosenbaum et al., 2002, Frodin et al., 1995). Long-term exposure 
to NGF in these experiments has been proposed to increase calcium currents via an increase 
in the synthesis of calcium channels, while a short 5 minute pulse of NGF can increase 
calcium conductance by stimulating the movement of channels to the cell surface, or 
modulating their activity through phosphorylation (Rosenbaum et al., 2002). In neonatal 
rat β-cells, increased calcium conductance in response to NGF can be attributed to both an 
increase in the surface localization of the α1c VGCC subunit and to an increase in the 
expression of the β2 VGCC that is enriched in adult β-cells (Navarro-Tableros et al., 2007). 
Besides calcium channels, sodium channels are also thought to contribute to the electrical 
excitability of β-cells. In rat β-cells, NGF increases the expression of type III sodium 
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channel α subunits, and enhances insulin secretion which is sensitive to the sodium channel 
blocker, tetrodotoxin. These effects are likely mediated by signaling through TrkA, as 
application of the selective tyrosine kinase inhibitor, K252a, was shown to block NGF-
induced increases in insulin secretion in dissociated rat β-cells (Rosenbaum et al., 2001). 
 While these studies convincingly demonstrate that NGF is capable of eliciting 
changes in the electrical properties of single dissociated rat β-cells, there are several caveats 
to the stated conclusions. First, the kinetics of insulin secretion between rat and mouse 
islets is known to differ (Ma et al., 1995), and sodium channels are thought to have a greater 
contribution to electrical activity in rat β-cells than either mouse or human β-cells (Misler 
et al., 1992). Second, it is not clear what significance these findings have in the context of 
insulin secretion in intact islets or in vivo. Here, we provide the first in vivo evidence that 
TrkA signaling in β-cells is required for normal glucose stimulated insulin secretion 
(GSIS). Furthermore, we demonstrate that acute TrkA activity in the adult mouse is 














TrkA-deficient mice exhibit impaired glucose tolerance and reduced insulin secretion
  
 It is clear that neurotrophin signaling has an indirect role in β-cell development via 
its role in promoting the proper development of the peripheral nervous system, however, it 
is less evident how neurotrophin signaling could directly impact β-cell development and 
function. To address the intrinsic role of TrkA in endocrine cells, we mated TrkAf/f with 
mice expressing Cre recombinase under the control of Pdx1, a transcription factor 
expressed in pancreatic progenitor cells. Pdx1-Cre;TrkAf/f mice would be expected to have 
an early and pancreas-wide deletion of TrkA. Biotinylated NGF ligand binding was 
markedly reduced in sections of pancreas from mutant islets (Fig. 3-1A,B), indicative of 
efficient TrkA deletion. In data previously published a thesis by Philip Borden, Pdx1-
Cre;TrkAf/f mice have been shown to survive to adulthood, have no gross morphological 
abnormalities, and have normal body weight (Borden, 2013). When we assessed metabolic 
parameters at the whole animal level, 1.5-2 month-old Pdx1-Cre;TrkAf/f mice were slightly 
hyperglycemic when fed ad libitum although fasted blood glucose levels were normal (Fig. 
3-1C,D). However, the Pdx1-Cre;TrkAf/f mice showed significant glucose intolerance with 
glucose administration (intra-peritoneally), and decreased circulating insulin levels 
compared to control TrkAf/f mice (Fig. 3-1E,F). Previous analysis of islet formation and 
cyto-architecture in neonatal Pdx1-Cre;TrkAf/f mice revealed no abnormalities however, 
mutant islets showed a modest decrease in size that was only apparent at one month of age 
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and this may be due, in part, to the trophic effects of NGF signaling on β-cell survival 
(Borden, 2013).   
 Although restricted Cre recombinase activity has been reported in extra-pancreatic 
tissues, including the hypothalamus, in Pdx1-Cre transgenic mice (Song et al., 2010), there 
is little overlap with TrkA expression (Fagan et al., 1997). Additionally, the Pdx1-CreTuv 
transgenic mice that we employed do not carry a human growth hormone mini-gene, 
commonly found in several Cre lines, that elicits metabolic defects. Together, these results 
suggest that loss of TrkA in pancreatic tissues causes the defects in glucose homeostasis 
and insulin secretion in Pdx1-Cre;TrkAf/f mice.   
 
TrkA kinase activity is acutely required for GSIS  
 In Pdx1-Cre;TrkAf/f mice, deletion of TrkA is initiated at early embryonic stages. 
Thus, the observations of impaired glucose tolerance and reduced insulin secretion in these 
mice could stem from developmental anomalies and/or acute deficits in insulin secretion. 
To distinguish between developmental versus acute effects of TrkA signaling, we 
employed a chemical-genetic approach to inducibly silence TrkA receptor tyrosine kinase 
activity in mature mice at 2 months of age. TrkAF592A knock-in mice express receptors 
with a mutated ATP binding pocket that can be selectively, rapidly and reversibly inhibited 
by a small molecule membrane-permeable inhibitor, 1NMPP1 (Chen et al., 2005) (Fig. 3-
2A). 1NMPP1 treatment markedly attenuated TrkA phosphorylation in islets isolated from 
TrkAF592A mice, but had no effect in wild-type islets (Fig. 3-2B,C). Importantly, acutely 
disrupting TrkA activity in vivo by injecting 1NMPP1 (20 ng/g body weight, intra-
peritoneally), 20 minutes prior to a glucose challenge, elicited glucose intolerance in adult 
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TrkAF592A mice (Fig. 3-2D), similar to the effects observed in Pdx1-Cre;TrkAf/f mice. 
The area under the curve (AUC) values of plasma glucose was significantly higher with 
1NMPP1 treatment compared to vehicle (DMSO) injection (Fig. 3-2E). Furthermore, 
TrkAF592A mice treated with 1NMPP1 showed attenuated insulin secretion in the first 
phase of a glucose challenge, as well as dampened insulin levels in the sustained second 
phase (Fig. 3-2F). Consistently, 1NMPP1 treatment also significantly decreased GSIS in 
TrkAF592A islets in static insulin secretion assays (Fig 3-2G).  
 There were no differences in total islet insulin content and insulin sensitivity, 
assessed by insulin tolerance assays, with 1NMPP1 versus vehicle injections in 
TrkAF592A mice (Fig. 3-2H,I). Thus, glucose intolerance in 1NMPP1-treated mice likely 
does not arise from defects in insulin biosynthesis and insulin responsiveness. Notably, 
1NMPP1 treatment did not alter glucose tolerance or insulin secretion in wild-type animals 
(Fig. 3-3A-C), highlighting that the effects of 1NMPP1 are specific in the context of the 
TrkAF592A mutation. Together, these results indicate that TrkA signaling acutely 










Figure 3-1: Conditional deletion of TrkA in the pancreas impairs glucose tolerance 
and insulin secretion 
(A,B) Biotinylated NGF binding is undetectable in Pdx1-Cre;TrkAf/f islets (outlined in red 
dashed line) compared to control TrkAf/f islets. Scale bar, 100 µm for (A,B). Representative 
images for (A,B) are shown from at least 3 animals per genotype that were analyzed. (C,D) 
Pdx1-Cre;TrkAf/f mice have normal fasted blood glucose levels, but are slightly 
hyperglycemic in the fed state. Values are the mean ± SEM for n=13 control, 14 mutant 
mice for (C) and n=19 control, 15 mutant mice for (D). *p<0.05, two-tailed t-test. (E,F) 
Pdx1-Cre;TrkAf/f mice have impaired glucose tolerance and reduced circulating insulin 
compared to TrkAf/f litter-mates. Mice were injected with glucose (2g/kg body weight) 
delivered intra-peritoneally (i.p.), after an overnight (16 hour) fast. Values are the mean ± 
SEM for n=13 control, 14 mutant mice for glucose tolerance tests, and n=4 mice per 
genotype for insulin secretion tests. *p<0.05, **p < 0.01, ***p<0.001, two-tailed t-test with 
Welch’s correction for unequal variance where necessary. Philip Borden contributed data 
to (C) n=8 control and n=14 mutant mice, (D) n=17 control and n=8 mutant mice, (E) n =7 


















Figure 3-2: Acute disruption of TrkA activity impairs glucose tolerance and insulin 
secretion  
(A) A chemical genetic strategy to inducibly silence TrkA kinase activity with the small 
molecule inhibitor, 1NMPP1, in TrkAF592A knock-in mice carrying a mutation in the ATP 
binding pocket. (B,C) 1NMPP1 (20µM) treatment for 20 minutes decreased TrkA 
phosphorylation in TrkAF592A islets, but had no effect on wild-type islets. Phospho-TrkA 
immunoblots were stripped and re-probed for TrkA for normalization. Densitometric 
quantification of phospho-TrkA levels normalized to total TrkA levels. Values are 
expressed relative to vehicle-treated TrkAF592A or wild-type islets. Results are means ± 
SEM from 3 independent experiments. *p<0.05, t-test. (D) Acute inactivation of TrkA 
signaling by 1NMPP1 injection (20ng/g body weight), 20 minutes prior to a glucose 
challenge, impaired glucose tolerance in TrkAF592A mice, compared to vehicle (DMSO) 
injection. Values are n=6 vehicle (DMSO)- and n=8 1NMPP1-injected TrkAF592A mice. 
*p<0.05, **p<0.01, t-test (E) Area under the curve (AUC) calculated for glucose tolerance 
test. *p<0.05, t-test. (F) In vivo glucose-stimulated insulin secretion is attenuated by 
1NMPP1 injection 20 minutes prior to the glucose challenge in TrkAF592A mice. Values are 
n=5 mice each for vehicle (DMSO)- and 1NMPP1-injections. *p<0.05, ***p<0.001, t-test. 
(G) Glucose stimulated insulin secretion is attenuated by 1NMPP1 pre-treatment (20µM, 
20 minutes) in isolated TrkAF592A islets. Values are means ± SEM from n=6 independent 
experiments. Islets were isolated from a total of 4-5 mice per experiment. ***p<0.001, 
two-way ANOVA with Bonferroni post-hoc test. (H) Total islet insulin content is normal 
with 1NMPP1 treatment (20µM, 20 minutes). Values are means ± SEM from n=5 
independent experiments. n.s. not significant, t-test. (I) Normal insulin sensitivity in 
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TrkAF592A mice treated with 1NMPP1 (20µM). A significant decrease in blood glucose 
levels was seen in both 1NMPP1- and vehicle-injected TrkAF592A mice, 15 minutes after 
insulin injection compared to t=0. Mice were treated with 0.75U/kg of insulin (i.p.), and 
blood glucose measured from tail blood at the indicated times post-injection. Values are 








Figure 3-3: 1NMPP1 treatment does not influence glucose tolerance or insulin 
secretion in wild-type mice 
(A) Glucose tolerance tests for wild-type mice injected with 1NMPP1 or vehicle (DMSO) 
20 minutes prior to an intra-peritoneal glucose challenge. (B) Area under the curve (AUC) 
analysis for glucose tolerance tests in (A). Values are means ± SEM for n=8 animals each 
for vehicle and 1NMPP1 injections. (C) Normal glucose-stimulated insulin secretion in 
wild-type islets treated with 1NMPP1. Values are means ± SEM from n=4 independent 
















 Previous work on neurotrophin regulation of metabolism has primarily focused on 
central hypothalamic circuits that control appetite and energy balance (Fargali et al., 2012, 
Rios, 2013). Despite the expression of neurotrophins and their receptors in peripheral 
metabolic tissues, little is known about peripheral mechanisms by which neurotrophins 
influence metabolism. Recently, p75 receptors in adipocytes were found to regulate energy 
expenditure and obesity, although this effect was independent of the p75 extracellular 
domain and neurotrophin binding (Baeza-Raja et al., 2016). Together, with our data from 
conditional NGF deletion from the vasculature, our findings in mice with a pancreas-
specific deletion of TrkA demonstrate a direct role for NGF/TrkA signaling in controlling 
insulin secretion and blood glucose homeostasis.   
 Prior studies focused on the effects of prolonged exposure to NGF on β-cell 
morphology, viability, and function. Here, we demonstrate that acute TrkA activity, during 
a glucose challenge, is important for GSIS in β-cells. Pancreas-specific deletion of TrkA 
was also found to result in reduced islet size, thus it is likely that loss of TrkA signaling 
has consequences for β-cell proliferation or survival in vivo. Additional analysis of Pdx-
Cre;TrkAf/f mice during development will be informative in elucidating a developmental 
role for neurotrophin signaling in β-cells. It is important to note that our work is of clinical 
relevance given that TrkA mutations have been linked to impaired glucose-stimulated 
insulin secretion in humans (Schreiber et al., 2005), and suggest the utility of neurotrophins 







All procedures relating to animal care and treatment conformed to Johns Hopkins 
University Animal Care and Use Committee (ACUC) and NIH guidelines. Mice were 
housed in a standard 12:12 light-dark cycle. Mice were maintained on a C57BL/6 
background, or mixed C57BL/6 and 129P, or C57BL/6 and FVB backgrounds. Both sexes 
were used for analyses at 1-2 months of age, unless stated otherwise in the figure legends. 
TrkAF592A (TrkAf/f) mice were obtained from the Jackson Laboratory (Stock No: 022362), 
and Pdx1-Cre mice (Tg(Pdx1-CreTuv), strain no: 01XL5) mice were obtained from NCI 
Frederick mouse repository.  
 
Antibodies 
Primary antibodies for western blots include rabbit anti-Phospho-TrkA (Tyr785)/TrkB 
(Tyr816) (1:1000, Cell Signaling C67C8) and rabbit anti-TrkA (1:1000, Millipore 06-574) 
 
Ligand binding 
Pancreatic NGF receptors were labeled by incubating 10 µm thick mouse tissue sections 
with biotinylated NGF (200ng/ml) for 1 hour at room temperature. Biotinylated NGF was 
prepared according to the manufacturer’s instructions using EZ-LinkTM Micro Sulfo-NHS-
Biotinylation kit (ThermoFisher Scientific, 21925). Following incubation with biotinylated 
NGF, tissue sections were washed and immunostained for insulin as described below. 
Biotinylated NGF was detected using Alexa-546-conjugated streptavidin (1:200, 
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Invitrogen, S11225). Sections were imaged using a Zeiss AxioImager M1 microscope 
equipped with an Axiocam HRc camera.  
 
Islet isolations 
Islets were isolated as previously described (Wollheim et al., 1990). Briefly, pancreata 
collected from 1-2-month old mice were distended using collagenase (Collagenase P, 0.375 
mg/ml, Roche) dissolved in Hank’s Balanced Salt Solution (HBSS, Mediatech), and 
digested at 37°C. Digested pancreata were washed with HBSS, and subjected to 
discontinuous density gradient centrifugation using varying histopaque densities (Sigma-
Aldrich). The islet layer was collected, washed with HBSS, and islets handpicked under an 
inverted microscope for subsequent analyses. 
 
Immunoblotting 
For detection of phosphorylated TrkA, isolated islets from TrkAF592A mice were allowed 
to recover overnight in RPMI 1640 medium containing 5% fetal bovine serum (FBS) and 
5 U/l penicillin/streptomycin. Islets were incubated with 1NMPP1 (20 µM) or vehicle 
(DMSO) dissolved in RPMI 1640 medium for 20 min, and then lysed in boiling laemmli 
buffer. For assessing glucose effects on TrkA phosphorylation, islets were pre-incubated 
in Krebs-Ringer HEPES buffer (KRHB) containing low (2.8 mM) glucose for 1 hour, and 
then either left in 2.8 mM glucose or stimulated with 16.7 mM glucose in KRHB buffer 
for 15 minutes, and lysates prepared in boiling laemmli buffer. Lysates were subjected to 
immunoblotting with rabbit anti-Phospho-TrkA (Tyr785)/TrkB (Tyr816), and membranes 
were later re-probed for rabbit anti-TrkA. All immunoblots were visualized with ECL Plus 
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Detection Reagent (Thermo Scientific, 32132) and scanned with a Typhoon 9410 Variable 
Mode Imager (GE Healthcare). Densitometric analysis of bands was performed using 
ImageJ software. 
 
In vivo analyses of glucose tolerance, insulin tolerance, and circulating insulin  
For glucose tolerance tests, 1-2 month-old mice were fasted overnight, with a blood glucose 
reading the evening before the assay serving as a fed blood glucose measurement. The next 
morning, mice were injected with glucose (2g/kg, i.p). Blood glucose measurements were 
made from tail blood using a OneTouch Ultra glucometer at the indicated times (Gu et al., 
2010). For acute treatments with 1NMPP1, mice received i.p. injections with 20ng/g 
1NMPP1 or DMSO, 20 minutes prior to glucose administration.  
 
For in vivo insulin and NGF secretion assays, mice were fasted overnight before being 
injected with glucose (3 g/kg, i.p.). Blood was collected from the tail at the times indicated, 
spun down, and the resulting plasma fractions subjected to insulin ELISA (Crystal Chem, 
90080). Reactions were assessed using a Tecan infinite 200 plate reader.  
 
For insulin sensitivity tests, mice were separated into individual cages with food the 
evening prior to the assay. The next morning, mice were treated with 0.75 U/kg of insulin 
(Novolin-R; Novo Nordisk), and blood glucose measurements were made from tail blood 
at the indicated times (Bruning et al., 1997). 
 
In vitro GSIS assays 
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For insulin secretion assays in isolated islets, harvested islets pooled from 4-5 mice were 
allowed to recover overnight in RPMI 1640 media containing 5% fetal bovine serum (FBS) 
and 5 U/l penicillin/streptomycin. Islets were washed in Krebs-Ringer HEPES buffer 
(KRHB) containing low (2.8 mM) glucose and allowed to stabilize for 1 hour. Islets were 
then pre-incubated with vehicle (DMSO) or 1NMPP1 (20µM) for 20 minutes. Groups of 
5-10 islets were then handpicked into 24-well dishes and incubated in low (2.8 mM) or 
high glucose (16.7 mM)  in KRHB buffer in the indicated conditions (vehicle or 1NMPP1) 
for another 30 minutes. Supernatant fractions were removed, the islets were lysed in acid 
ethanol, followed by insulin ELISA (Crystal Chem) to determine the insulin concentrations 
in both supernatant and islet fractions. 
 
For insulin content measurements, TrkAF592A islets incubated in low glucose-KRHB media 
were treated with 1NMPP1 (20µM) or DMSO for 20 minutes. Islets were lysed with acid 
ethanol, and insulin content was determined by ELISA and normalized to DNA content, 
measured from the same lysates using a PicoGreen kit (Invitrogen). Absorbance readings 














CHAPTER 4: TRKA SIGNALING IS REQUIRED FOR GLUCOSE 
STIMULATED INSULIN GRANULE RECRUITMENT AND ACTIN 




Portions of this chapter were previously submitted for publication at Developmental Cell:  
Jessica Houtz, Philip Borden, Alexis Ceasrine, and Rejji Kuruvilla (2016). Neurotrophin 















Actin remodeling regulates GSIS 
 The disparate roles of actin in regulated exocytosis have been well-documented 
with evidence to support both negative and positive effects in vesicle secretion (Porat-
Shliom et al., 2013, Kalwat and Thurmond, 2013, Varadi et al., 2005, Schuh, 2011). On 
the one hand, F-actin tracks are needed for mobilizing vesicles from deeper reserve pools 
to the plasma membrane (Varadi et al., 2005, Schuh, 2011). On the other hand, cortical F-
actin acts as a physical barrier to limit exocytosis in diverse cell types including endocrine, 
chromaffin, immune cells and neurons (Porat-Shliom et al., 2013, Kalwat and Thurmond, 
2013). In β-cells, the barrier function of the cytoskeleton has been proposed to be critical 
for maintaining low levels of insulin release under basal conditions (Kalwat and Thurmond, 
2013). Importantly, the presence of a dense cytoskeletal meshwork at the cell periphery 
presents a layer of regulation for controlled insulin release under elevated glucose (Zhu et 
al., 2015).  
 Each individual β-cell contains approximately 10,000 secretory granules of insulin 
but only a fraction (several hundreds) are released at a time in response to high glucose, 
emphasizing the precise regulation of release probability of insulin granules (Rorsman and 
Renstrom, 2003). The relevance of actin dynamics in glucose homeostasis is exemplified 
by genetic studies in mice where deletion of Rac1, or its effector, p21-activated kinase 
(PAK), elicits glucose intolerance and diminished insulin secretion (Asahara et al., 2013, 
Wang et al., 2011). Notably, a 10-fold increase in total cellular actin has been observed in 
islets from type 2 diabetes patients (Ostenson et al., 2006). Although a number of actin 
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regulators of glucose-stimulated insulin secretion including Rac1, Cdc42, PAK, Focal 
Adhesion Kinase (FAK), cofilin, and gelsolin, have been identified in β-cells (Thurmond 
et al., 2003, Kalwat and Thurmond, 2013), the events upstream of these actin-modulatory 
proteins have remained unclear. 
 
NGF signaling through TrkA regulates cytoskeletal dynamics in sympathetic neurons 
 In neurons, the cytoskeleton is important for determining the structure of axonal 
and dendritic arborizations. Neurotrophins have well-established roles in influencing 
neurite formation, axon outgrowth and branching, and dendritic complexity (Gallo and 
Letourneau, 2000, McAllister et al., 1999, Ruit and Snider, 1991). Additionally, 
neurotrophin signaling can directly impact levels of cytoskeletal proteins, in particular 
filamentous actin (F-actin), in growth cones by affecting both protein and mRNA 
localization (McAllister et al., 1999, Zhang et al., 1999, Wickramasinghe et al., 2008). 
NGF has also been demonstrated to influence axon growth by stabilizing neurofilaments 
(Veeranna et al., 1998) and modulating GSK-3β and the plus-end microtubule binding 
protein, APC, to stabilize microtubules in the axon shaft. Besides directly affecting 
elements of the cytoskeleton, NGF can stimulate the autocrine production of Wnt5a to 
indirectly promote axon branching during development (Bodmer et al., 2009). 
 Studies have shown that TrkA forms signaling endosomes that associate with Rap1 
(Wu et al., 2001, York et al., 1998, York et al., 2000) which could provide a platform on 
which interacting proteins such as RIAM and the Rho family of small GTPases may 
accumulate to regulate actin dynamics in the growth cone. Numerous lines of evidence 
suggest that NGF affects cellular processes in axons via modulation of cytoskeletal-
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associated protein such as actin depolymerizing factor (ADF) and Rac1, and recent work 
has highlighted an important role for TrkA endocytosis in mediating local actin 
depolymerization to enable retrograde transport of NGF signals through the dense F-actin 
meshwork in axons (Harrington et al., 2011). 
 Since regulation of actin dynamics is a shared feature of both neurotrophin 
signaling in neurons and glucose stimulated insulin secretion in β-cells, we hypothesized 
that TrkA signaling might be affecting insulin secretion through its influence on actin 
remodeling. In this chapter, we show a previously unappreciated mechanism through which 



















TrkA signaling is required for surface-localization of insulin granules 
 Regulatory control of insulin secretion can occur at the level of glucose uptake and 
metabolism in β-cells, β-cell membrane depolarization, and insulin granule mobilization 
and exocytosis (MacDonald et al., 2005). A key question is, which step in this stimulus-
secretion coupling pathway is affected by TrkA signaling? Exposure to high extracellular 
K+ is a well-established experimental strategy to depolarize the β-cell plasma membrane, 
thus by-passing the need for glucose uptake and metabolism to trigger insulin secretion 
(Hatlapatka et al., 2009). Elevated potassium chloride (KCl) results in the opening of 
voltage-dependent Ca2+ channels to promote the exocytosis of secretion-ready insulin 
granules (Hatlapatka et al., 2009). To determine if the requirement for TrkA signaling in 
insulin secretion was downstream of glucose sensing and metabolism, we assessed the 
effects of 1NMPP1 on KCl-induced insulin secretion. 1NMPP1-mediated inhibition of 
TrkA activity abolished insulin secretion induced by high KCl (30mM) in TrkAF592A 
islets (Fig. 4-1A). These results suggest that TrkA signaling is required in the step(s) of the 
insulin secretory pathway that is distal to membrane depolarization. 
 To further probe the requirement for TrkA activity in insulin secretion, we 
employed ultra-structural analyses. Electron microscopy revealed an increase in insulin 
granule localization at the β-cell plasma membrane in response to an in vivo glucose 
challenge compared to the fasted state in TrkAF592A mice (Fig. 4-1B,C, and F). 
However, 1NMPP1 injection, 20 minutes prior to glucose administration, suppressed the 
glucose-induced recruitment of insulin granules to the cell periphery, but had no effect on 
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insulin docking under basal conditions (Fig. 4-1D,E, and F). 1NMPP1-treated β-cells had 
fewer docked insulin granules (quantified as granules within 50 nm of the plasma 
membrane) in the presence of high glucose, although total number of insulin granules and 
their sizes were normal. Since islet insulin content was unaffected by 1NMPP1 treatment 
(see Chapter 3 Fig. 3-2H), the reduction in surface-localized insulin granules is likely not 
due to defects in insulin biogenesis. Together, these results suggest that TrkA activity is 
necessary for glucose-dependent insulin granule positioning at the β-cell surface.  
 
TrkA signaling is required for F-actin remodeling in β-cells 
 Given that a brief (20 minute) exposure to 1NMPP1 was sufficient to elicit glucose 
intolerance and attenuate GSIS in TrkAF592A mice, we reasoned that TrkA signaling 
likely influences insulin secretion by mechanisms independent of gene transcription. Actin 
rearrangement is a critical acute determinant of GSIS35. Actin microfilaments are 
organized as a dense meshwork beneath the β-cell plasma membrane that restricts insulin 
granule access to the docking and fusion machinery (Orci et al., 1972, van Obberghen et 
al., 1973, Li et al., 1994). Glucose stimulation rapidly promotes filamentous actin (F-actin) 
remodeling to mobilize insulin granules to the cell periphery (Kalwat and Thurmond, 
2013), (Howell and Tyhurst, 1986, Thurmond et al., 2003, Wang and Thurmond, 2009). 
However, how glucose stimulation regulates actin reorganization has remained unclear. 
 Remodeling of the actin cytoskeleton is also a key cellular process by which 
neurotrophins control vesicular trafficking in neurons (Harrington and Ginty, 2013). Thus, 
we asked whether TrkA signaling promotes actin rearrangements in β-cells, a pre-requisite 
step in insulin granule positioning at the plasma membrane. Isolated TrkAF592A β-cells 
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were pre-treated with 1NMPP1 for 20 minutes prior to stimulation with either low (2.8 
mM) or high glucose (16.7 mM), and F-actin was visualized using Alexa-546-labeled 
phalloidin. Under basal conditions (2.8 mM glucose), both vehicle and 1NMPP1-treated 
β-cells showed a thick F-actin cortical ring (Fig. 4-2A,C). High glucose treatment elicited 
a striking reduction in F-actin (Fig. 4-2B,E), consistent with previous reports (Nevins and 
Thurmond, 2003, Cai et al., 2012). However, the glucose-induced dissolution of F-actin 
was prevented by 1NMPP1-mediated silencing of TrkA signaling (Fig. 4-2D,E). Thus, 
TrkA activity is required for glucose-triggered actin reorganization in β-cells. 
 Glucose-mediated actin remodeling in β-cells depends on the activities of several 
actin-modulatory proteins including the Rac1 GTPase (Kalwat and Thurmond, 2013). In 
clonal β-cell lines and in islets, elevated glucose stimulates Rac1 activity (Kowluru, 2011). 
β-cell-specific deletion of Rac1 inhibits F-actin disassembly and impairs glucose tolerance 
and GSIS in mice (Asahara et al., 2013). Rac1-deficient β-cells also show impaired 
glucose-dependent recruitment of insulin granules to the β-cell membrane (Asahara et al., 
2013), similar to that seen with TrkA inhibition. However, how elevated glucose activates 
Rac1 remains unclear. Using an ELISA-based immunoassay, we observed that high 
glucose treatment for 15 minutes significantly increased GTP-bound Rac1 levels (1.8 ± 
0.15-fold increase) in TrkAF592A islets, which was suppressed by TrkA inhibition with 
1NMPP1 (Fig. 4-2F). These results suggest that TrkA kinase activity is required for 
glucose-mediated activation of Rac1.  
 We next reasoned that if indeed a perduring F-actin barrier was a key contributor 
to decreased GSIS upon TrkA inhibition, then forcing F-actin disassembly should alleviate 
impaired secretion in 1NMPP1-treated islets. To test this prediction, we assessed insulin 
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secretion in islets that were co-treated with 1NMPP1 and cytochalasin D, an actin 
depolymerizing agent. As expected, 1NMPP1 treatment alone attenuated GSIS compared 
to vehicle (DMSO) in TrkAF592A islets (Fig. 4-2G). Remarkably, a normal insulin 
secretory response in response to elevated glucose was observed in TrkAF592A islets 
treated with both 1NMPP1 and cytochalasin D (Fig. 4-2G). Together, these results indicate 






















Figure 4-1: TrkA signaling regulates surface recruitment of insulin granules  
 (A) TrkA signaling is necessary for KCl-induced insulin secretion. Pre-treatment with 
1NMPP1 (20µM, 20 minutes) suppresses insulin secretion in response to high KCl (30 
mM, 30 minutes) in isolated TrkAF592A islets. Values are mean ± SEM from n=5 
independent experiments. **p<0.01, ***p<0.001, n.s. not significant, two-way ANOVA 
with Bonferroni post-test. (B-E) TrkA signaling is necessary for glucose-induced surface 
localization of insulin granules. Electron microscopic analysis of β-cells shows more 
docked insulin granules (red arrowheads) in response to a glucose challenge, compared to 
the fasted state, in TrkAF592A mice. 1NMPP1 injection, 20 minutes prior to glucose delivery, 
decreases the glucose-induced recruitment of insulin granules. 1-2 month-old TrkAF592A 
mice were fasted overnight and then injected with vehicle or 1NMPP1 (20ng/g, i.p.), 20 
minutes prior to an in vivo glucose challenge (2g/kg, i.p.). At least three islets were selected 
at random per animal, and representative images of β-cells per islet taken. Insulin granules 
within 50 nm of the plasma membrane were considered as docked granules. Scale bar, 1 
µm. (F) Quantification of docked insulin granules per micron of plasma membrane 
observed in electron microscopy experiments. Values are mean ± SEM from n=3 mice each 
for vehicle and 1NMPP1 injections, **p<0.01, n.s. not significant, two-way ANOVA with 











Figure 4-2: TrkA activity is required for glucose-stimulated actin remodeling 
(A-D) High glucose (16.7 mM) treatment for 30 minutes markedly decreases F-actin levels 
in primary β-cells from TrkAF592A mice, compared to low glucose (2.8 mM) conditions. 
Glucose-dependent changes in F-actin were prevented by pre-treatment of β-cells with 
1NMPP1 (20 µM, 20 minutes). F-actin is marked by Alexa-546-phalloidin (in red) and β-
cells in islet cultures were identified by insulin immunostaining (in green). Scale bar, 5µm. 
(E) Average fluorescence intensity for F-actin. Values are mean ± SEM from n=7 
independent experiments, 20-25 cells were analyzed per condition per experiment. 
*p<0.05, **p<0.01, n.s. not significant, two-way ANOVA with Bonferroni post-test. (F) 
Levels of Rac1-GTP are enhanced by elevated glucose treatment (16.7 mM, 15 min) in 
TrkAF592A islets. Pre-incubation of islets with 1NMPP1 for 20 minutes attenuates the 
glucose-induced increase in Rac1 activity. Values are mean ± SEM from n=5 independent 
experiments, *p<0.05, two-way ANOVA with Bonferroni post-test. (G) Defects in 
glucose-induced insulin secretion with 1NMPP1 treatment in TrkAF592A islets were fully 
rescued by cytochalasin D, an actin depolymerizing agent. TrkAF592A islets were pre-treated 
with vehicle, 1NMPP1 (20 µM), or 1NMPP1 (20 µM) plus cytochalasin D (25 µM) for 20 
minutes, and then stimulated with 16.7 mM glucose or maintained in 2.8 mM glucose for 
30 minutes, followed by measurements of insulin content in supernatants and islet lysates. 
Values are mean ± SEM from n=6 independent experiments. ***p<0.001, n.s. not 













 Biphasic insulin secretion involves an immediate, first phase in which a limited 
number of pre-docked and primed insulin granules rapidly fuse with the plasma membrane 
in response to calcium influx, and a sustained second phase that requires insulin granule 
recruitment (Henquin et al., 2003, Rorsman and Renstrom, 2003). Recent work has 
demonstrated that elements of the cytoskeleton are dynamically regulated to ensure that 
insulin secretion remains low under basal insulin secretion and remains elevated as long as 
glucose levels are high (Kalwat and Thurmond, 2013). We identified a crucial role for 
TrkA activity, downstream of glucose sensing and metabolism, in regulating β-cell actin 
dynamics to allow insulin granule recruitment to the plasma membrane.   
 Deficits in insulin secretion induced by forced β-cell depolarization, similar to our 
own observations in islets stimulated with KCl while TrkA activity was inhibited (Fig. 4-
1A), could indicate an impairment of voltage-gated calcium channels, and there is evidence 
to support NGF mediated increases in calcium currents in β-cells (Rosenbaum et al., 2002). 
We do not rule out the possibility that TrkA may influence calcium dynamics in β-cells, 
however our data supports a significant role for TrkA activity in regulating insulin secretion 
through actin remodeling, since actin depolymerization was able to rescue insulin secretion 
back to normal levels (Fig. 4-2G).  
Interestingly, some actin remodelers, such as gelsolin (Kalwat et al., 2012) and scinderin 
(Bruun et al., 2000), are thought to regulate actin dynamics downstream of calcium in β-
cells. Conversely, actin depolymerization has been implicated in the regulation of calcium 
entry via the endoplasmic reticulum (ER) (Patterson et al., 1999, Rosado and Sage, 2000), 
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which is also at play during the cephalic phase of insulin secretion (Ahrén et al., 2006), and 
could operate downstream of TrkA signaling via activation of PLCγ. Cortical actin is 
known to displace endoplasmic reticulum (ER) that acts as a reservoir of intracellular 
calcium, and cycles of actin dypolymerization and cytosolic calcium are known to regulate 
pulsatile vesicle secretion (Wollman and Meyer, 2012). There is also data supporting a role 
for actin deploymerization in generating Ca2+ mobilization signals during GSIS in β-cells 
(Shawl et al., 2012). Given that β-cell edges have been shown to be enriched in filamentous 
actin, and are sites of the greatest increases in [Ca2+]i (Geron et al., 2015), it is possible that 
TrkA-mediated actin remodeling contributes to the pulsatile nature of Ca2+ dynamics and 
insulin secretion in β-cells.  
 Impairments in KCl-induced insulin secretion are also typically associated with 
reduced fusion of pre-docked insulin granules. Our data indicate that inhibition of TrkA 
activity reduces insulin secretion upon depolarization without influencing the ability of 
granules to dock to the membrane in basal conditions. There is data to support the 
contribution of “restless newcomer” granules that fuse directly with the plasma membrane 
without docking (Shibasaki, T., et al., PNAS 2007, Predersen, MG., Sherman, A., PNAS 
2009). Thus, it is possible that TrkA activity could contribute to movement of granules 
during the first phase of insulin secretion, and inhibition of TrkA activity may influence 
first phase insulin secretion independently of regulating insulin granule docking. In support 
of this notion, patients with mutations in the TrkA gene have congenital insensitivity to 
pain and anhidrosis (CIPA) (Indo et al., 1996) and have been characterized to have deficits 
in first phase insulin secretion (Schreiber et al., 2005). Elucidating the mechanistic 
regulation behind these different pools of insulin granules in the first phase response could 
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be accomplished with recent advances in TIRF microscopy and reporters for insulin 



























All procedures relating to animal care and treatment conformed to Johns Hopkins 
University Animal Care and Use Committee (ACUC) and NIH guidelines. Mice were 
housed in a standard 12:12 light-dark cycle. Mice were maintained on a C57BL/6 
background, or mixed C57BL/6 and 129P, or C57BL/6 and FVB backgrounds. Both sexes 
were used for analyses at 1-2 months of age, unless stated otherwise in the figure legends. 




Primary antibodies for immunofluorescence include guinea pig anti-insulin (1:300, abcam 
ab7842). Fluorescent secondary antibodies were Alexafluor-350, -488,-546, or -647-
conjugated and used at 1:200 (Invitrogen)  
 
Islet isolations 
Islets were isolated as previously described (Wollheim et al., 1990). Briefly, pancreata 
collected from 1-2 month old mice were distended using collagenase (Collagenase P, 0.375 
mg/ml, Roche) dissolved in Hank’s Balanced Salt Solution (HBSS, Mediatech), and 
digested at 37°C. Digested pancreata were washed with HBSS, and subjected to 
discontinuous density gradient centrifugation using varying histopaque densities (Sigma-
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Aldrich). The islet layer was collected, washed with HBSS, and islets handpicked under an 
inverted microscope for subsequent analyses. 
 
Electron microscopy 
1-2 month old TrkAF592A mice were separated into individual cages and fasted overnight, 
and subjected to either 1NMPP1 (20 ng/g body weight, Cayman Chemical) or DMSO 
injections administered intra-peritoneally (i.p.). After 20 minutes, pancreata were 
immediately collected for control conditions, or mice were injected with glucose (Sigma 
Aldrich, 2 g/kg body weight, i.p). 15 minutes after glucose administration, minced, and 
fixed in buffer containing 3% formaldehyde, 1.5% glutaraldehyde, 5mM CaCl2, 2.5% 
sucrose, and 0.1M sodium cacodylate for 1hr at room temperature. Tissues were post-fixed 
in 1% Palade’s OsO4 for 1hr on ice, followed by incubation in Kellenberger’s uranyl 
acetate overnight at room temperature. After dehydration through graded alcohols, tissues 
were embedded in Epon, and ultrathin (∼90 nm) sections were collected onto EM grids. 
Grids were then imaged using an FEI Tecnai-12 TWIN transmission electron microscope 
operating at 100 kV. For each image, the number of granules within 50 nm of the plasma 
membrane was determined using ImageJ software. Results were expressed as average 
number of docked insulin granules per µm of the plasma membrane, determined for 3-4 
islets per animal, and 3 animals per condition. 
 
In vitro GSIS assays 
For insulin secretion assays in isolated islets, harvested islets pooled from 4-5 mice were 
allowed to recover overnight in RPMI 1640 media containing 10% fetal bovine serum 
79 
 
(FBS) and 5 U/l penicillin/streptomycin. Groups of 5-10 islets of similar size were 
handpicked into 24-well dishes, washed in Krebs-Ringer HEPES buffer (KRHB) 
containing low (2.8 mM) glucose and allowed to stabilize for 1 hour. Islets were then pre-
incubated with vehicle (DMSO), 1NMPP1 (20µM), or 1NMPP1 (20 µM) plus cytochalasin 
D (25µM, Cayman Chemical) for 20 minutes. Groups of 5-10 islets were then incubated in 
low (2.8 mM) or high glucose (16.7 mM), or KCl (30 mM, Sigma-Aldrich) in KRHB buffer 
in the indicated conditions (Vehicle, 1NMPP1, or 1NMPP1 plus cytochalasin) for another 
30 minutes. Supernatant fractions were removed, the islets were lysed in acid ethanol, 
followed by insulin ELISA (Crystal Chem) to determine the insulin concentrations in both 
supernatant and islet fractions. 
 
Phalloidin staining 
Islets were isolated from adult 1-2 month old TrkAF592A mice and dissociated into single 
cells by gentle trituration in HBSS containing 4 mM EDTA. Cells were resuspended in 
RPMI 1640 media containing 5% FBS and 5 U/l penicillin/streptomycin, and plated on 
glass coverslips coated with poly-D lysine. After 24 hours, islet cultures were treated with 
1NMPP1 (20 µM) or DMSO for 20 minutes, followed by incubation in low (2.8 mM) or 
high (16.7 mM) glucose for another 30 minutes. Cells were fixed in 4% PFA and stained 
with Alexa546–conjugated phalloidin (Invitrogen). β-cells were identified by 
immunostaining for insulin. Images representing 1µm optical sections were acquired using 
a Zeiss LSM 510 confocal microscope. Average fluorescence intensities of Alexa-546 per 
μm2 in individual β-cells were measured using ImageJ software (NIH). 20-25 cells were 




To assess the effects of endocytosis-defective TrkA receptors on F-actin, isolated β-cells 
from TrkAF592A mice were incubated with adenoviruses expressing either FLAG-TrkAY794F 
or control FLAG-TrkA receptors, and treated with doxycycline (100 ng/ml) in RPMI 1640 
media containing 5% FBS and 5 U/l penicillin/streptomycin for 24 hours. β-cells were then 
incubated in 1NMPP1 (20μM) for 20 minutes to silence endogenous TrkA receptors, and 
then fixed and labeled with Alexa546–phalloidin as described above. 
 
Rac1 activity  
GTP-bound Rac1 levels in islet lysates were measured using Rac1 G-protein linked 
immunosorbent assay (G-LISA) (Cytoskeleton Inc., Cat. # BK126). Islets were treated with 
1NMPP1 (20 µM) or DMSO for 20 minutes, followed by incubation in low (2.8 mM) or 
high (16.7 mM) glucose for another 15 minutes. Islet protein concentrations were measured 
using Precision Red Advanced Protein Assay (Cytoskeleton Inc., Cat. # ADV02-A), and 



















Portions of this chapter were previously submitted for publication at Developmental Cell:  
Jessica Houtz, Philip Borden, Alexis Ceasrine, and Rejji Kuruvilla (2016). Neurotrophin 

















TrkA signaling mechanisms 
 TrkA belongs to the family of high affinity neurotrophin receptor tyrosine kinases, 
and as such activates well characterized downstream signaling pathways including MAPK, 
PI3K, and PLC gamma (PLCγ) to mediate complex cell processes (Chao, 2003). Canonical 
receptor tyrosine kinase signaling begins with ligand binding at the extracellular domain 
of the receptor and subsequent dimerization, which leads to auto-phosphorylation of the 
intracellular kinase domain. Intracellular activation of the receptor results in 
phosphorylation at highly conserved tyrosine residues that recruit and activate cytoplasmic 
signaling effectors. Specifically, phosphorylation of tyrosine 499 (Y499) in TrkA is known 
to be required for recruitment and activation of the adaptor protein, Shc that leads to the 
activation of the MAPK and PI3K pathways (Segal et al., 1996, Stephens et al., 1994), 
phosphorylation of tyrosine 760 (Y760) specifically recruits the p85 catalytic subunit of 
PI3K (Obermeier et al., 1993), and tyrosine 794 (Y794) is required for PLCγ activation by 
TrkA. 
 While the immediate and local effects of NGF on axon growth and branching are 
fairly easy to envision, NGF signaling through TrkA at growth cones is also propagated 
back to the cell body to regulate synaptogenesis and transcriptional changes (Huang and 
Reichardt, 2001a). The mechanisms by which distal NGF signaling is able to influence cell 
processes in the cell body, located a distance up to 1000x the diameter of the cell body, has 
been the topic of extensive research for many decades. Although several hypotheses were 
initially proposed for the retrograde transport of NGF signaling, including propagation of 
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waves of TrkA activity along the cell surface of the axon (Ginty and Segal, 2002, Senger 
and Campenot, 1997), the best supported model involves internalization of TrkA-NGF into 
a signaling endosome that is retrogradely transported to the cell body. There are numerous 
studies to support the transport of NGF and TrkA in an active complex, including co-
localization, co-immunoprecipitation, and accumulation of labeled NGF (applied to targets 
in vivo) back in the cells body. Furthermore application of inhibitors to proximal axons did 
not impair the ability of distal NGF to elicit the accumulation of activated TrkA and 
downstream effectors in the cell body. While the precise mechanism of TrkA 
internalization is unknown, with evidence to support clathrin and caveolin -dependent and 
-independent endocytosis as well as micropinocytosis(Valdez et al., 2005, Ginty and Segal, 
2002), it is clear that most TrkA internalization depends upon dynamin that mediates 
pinching of clathrin coated vesicles from the membrane (Ye et al., 2003, Zhang et al., 
2000). Specifically, TrkA activation of PLCγ is necessary for calcineurin-mediated de-
phosphorylation of dynamin-1 to promote TrkA internalization (Bodmer et al., 2011). 
 Once internalized, TrkA continues to associate with NGF leading to persistent 
signaling from endosomes. These TrkA signaling endosomes recruit effectors including 
small GTPases (Rab, Ras, Rap) and components of MAPK and PI3K signaling pathways 
to regulate trafficking of the receptor and local signaling. Interestingly, TrkA 
internalization appears to be required for both local NGF mediated axon growth as well as 
retrograde survival signaling (Bodmer et al., 2011). This may be due to sustained signaling 
which can occur from endosomes that are protected from silencing by membrane 
associated phosphatases or lysosomal degradation (Wu et al., 2001, Bodmer et al., 2011, 
York et al., 1998, York et al., 2000). Recent data has found that TrkA endocytosis is 
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required to activate the actin remodelers Rac1 and cofilin to “carve a path” through dense 
axonal actin to enable retrograde transport (Harrington et al., 2011). Although β-cells are 
not as highly polarized as neurons, we were curious as to whether TrkA endocytosis in β-
cells is a conserved and necessary process through which neurotrophin signaling mediates 
glucose induced actin remodeling. We used a combination of surface biotinylation and 
antibody feeding techniques that have been well established in neurons to test whether or 
not TrkA internalization occurs in β-cells. We find that TrkA is endocytosed in β-cells and 




















TrkA undergoes endocytosis in β-cells 
 In neurons, endosomal signaling from intracellular TrkA receptors is a key 
determinant of actin remodeling (Harrington et al., 2011). NGF promotes endocytosis of 
its TrkA receptors in nerve endings into signaling endosomes that are retrogradely 
transported to neuronal cell bodies to activate trophic signaling (Ascano et al., 2012). 
Endosomal TrkA signaling overcomes a dense peripheral actin network in axons to “carve 
a path” for retrogradely moving vesicles (Harrington et al., 2011). These findings raise the 
possibility of an analogous mechanism in β-cells where internalized TrkA receptors and 
neurotrophin signaling endosomes might mediate changes in F-actin necessary for insulin 
granule mobilization.  
 To address this possibility, we first asked whether TrkA receptors undergo ligand-
dependent endocytosis in β-cells. We probed TrkA endocytosis using a cell surface 
biotinylation assay in the MIN6 mouse insulinoma cell line that exhibits many 
characteristics of primary β-cells including GSIS, and have been widely used for 
biochemical analyses (Ishihara et al., 1993). NGF stimulation for 30 minutes markedly 
increased TrkA endocytosis compared to un-stimulated cells (Fig. 5-1A,B). Furthermore, 
we visualized the trafficking of surface TrkA receptors in primary β-cells by using a well-
established antibody-feeding assay (Ascano et al., 2009). Primary β-cells were infected 
with an adenoviral vector expressing FLAG-tagged chimeric receptors that have the 
extracellular domain of TrkB and the transmembrane and intracellular domains of TrkA 
(FLAG-TrkB:A). The chimeric Trk receptors respond to the TrkB ligand, Brain-Derived 
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Neurotrophic Factor (BDNF), but retain the signaling properties of TrkA (Ascano et al., 
2009). Live-cell immunocytochemistry with FLAG antibodies revealed predominantly 
surface localization of the receptors in the absence of ligand (Fig. 5-1C). However, in 
BDNF-stimulated β-cells, Trk receptors accumulated in intracellular punctae that co-
localized with Early Endosome Antigen 1 (EEA1), an early endosome marker (Fig. 5-1D, 
E). Thus, ligand-mediated endocytosis of Trk receptors is a conserved mechanism that 
occurs in both pancreatic β-cells and neurons. 
 
Mechanisms mediating TrkA internalization in β-cells 
 Previous work has shown that TrkA activation of PLCу1 is necessary for 
calcineurin mediated TrkA endocytosis (Bodmer et al., 2011). When either PLCу1 or 
calcineurin activity is blocked, NGF dependent TrkA internalization is significantly 
diminished in neurons. Interestingly we find that inhibition of PLCу1, but not calcineurin 
impairs internalization of biotinylated TrkA receptors in MIN6 cells (Fig. 5-1F,G). In 
neurons, activation of calcineurin is required to interact with and de-phosphorylate 
dynamin-1ab to induce TrkA internalization. It is possible that this discrepancy in 
calcineurin dependence for TrkA internalization may be due to differences in expression 
of dynamin isoforms between β-cells and neurons (Raimondi, 2011, Lu et al., 2008).  
 Phosphorylation of TrkA receptors at a specific tyrosine residue, Y794, is necessary 
for PLCγ recruitment (Stephens et al., 1994). To assess the requirement of Y794 
phosphorylation for TrkA endocytosis in β-cells, we performed antibody-feeding assays in 
MIN6 cells transfected with mutant FLAG-TrkAY794F or control FLAG-TrkA receptors. 
Upon NGF treatment, FLAG-TrkA receptors were found in intracellular punctae, whereas 
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mutant FLAG-TrkAY794F receptors remained largely at the cell surface (Fig. 5-1H,I,J, 
and L). Furthermore, FLAG-TrkAY499F receptors, mutated at a site necessary for 
recruitment of the adaptor protein, Shc, and coupling to downstream MAP kinase and 
phosphatidylinositol 3-kinase (PI-3K) effector pathways, were internalized normally in 
response to ligand (Fig. 5-1K and L). Thus, TrkA phosphorylation at Y794 and activation 
of PLCγ are selectively required for endocytosis in β-cells, as in neurons. 
 
Endocytosed TrkA receptors mediate actin reorganization and insulin secretion 
 To investigate the effects of endocytosis-deficient Trk receptors on actin 
remodeling and insulin secretion in primary β-cells and islets, we generated adenoviral 
vectors expressing mutant FLAG-TrkAY794F or control FLAG-TrkA receptors, that were 
also doxycycline-inducible to precisely control expression. FLAG-tagged receptors were 
expressed in a doxycycline-dependent manner and also appeared normally on the cell 
surface in infected MIN6 cells (Fig. 5-2A). To assess the effects of ectopic TrkA receptors 
on glucose-induced actin remodeling, isolated β-cells from TrkAF592A mice were infected 
with FLAG-TrkA adenoviruses, treated with doxycycline (100 ng/ml) for 24-30 hr, and 
then treated with 1NMPP1 for 20 minutes to silence endogenous TrkA activity. The FLAG-
TrkA receptors are impervious to 1NMPP1 since they do not harbor the F592A mutation. 
β-cells were then exposed to low (2.8 mM) or high (16.7 mM) glucose, and F-actin 
visualized with phalloidin labeling. We found that ectopic expression of control FLAG-
TrkA receptors promoted glucose-dependent actin reorganization in 1NMPP1-treated cells 
(Fig. 5-1M, N and Q). In contrast, mutant FLAG-TrkAY794F receptors were unable to 
rescue the 1NMPP1-mediated impairment in actin reorganization (Fig. 5-1O-Q).  
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 In insulin secretion assays, control FLAG-TrkA receptors elicited robust insulin 
secretion in response to glucose, despite the presence of 1NMPP1 (Fig. 5-1R). However, 
glucose-stimulated insulin secretion was suppressed in islets expressing mutant FLAG-
TrkAY794F receptors (Fig. 5-1R). Furthermore, PLCγ inhibition also decreased GSIS in 
islets, similar to the effects of the non-internalizable TrkA receptors (Fig. 5-2B). These 
results suggest that TrkA endocytosis, via PLCγ activity, is required for glucose-stimulated 
actin remodeling and insulin secretion. 
 
Mechanisms mediating TrkA internalization in β-cells 
 Previous work has shown that TrkA activation of PLCу1 is necessary for 
calcineurin mediated TrkA endocytosis (Bodmer et al., 2011). When either PLCу1 or 
calcineurin activity is blocked, NGF dependent TrkA internalization is significantly 
diminished in neurons. Interestingly we find that inhibition of PLCу1, but not calcineurin 
impairs internalization of biotinylated TrkA receptors in MIN6 cells (Fig 5-1F,G). In 
neurons, activation of calcineurin is required to interact with and de-phosphorylate 
dynamin-1ab to induce TrkA internalization. It is possible that this discrepancy in 
calcineurin dependence for TrkA internalization may be due to differences in expression 
of dynamin isoforms between β-cells and neurons (Raimondi, 2011, Lu et al., 2008).  
 Phosphorylation of TrkA receptors at a specific tyrosine residue, Y794, is necessary 
for PLCγ recruitment (Stephens et al., 1994). To assess the requirement of Y794 
phosphorylation for TrkA endocytosis in β-cells, we performed antibody-feeding assays in 
MIN6 cells transfected with mutant FLAG-TrkAY794F or control FLAG-TrkA receptors. 
Upon NGF treatment, FLAG-TrkA receptors were found in intracellular punctae, whereas 
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mutant FLAG-TrkAY794F receptors remained largely at the cell surface (Fig. 5-1H,I,J, 
and L). Furthermore, FLAG-TrkAY499F receptors, mutated at a site necessary for 
recruitment of the adaptor protein, Shc, and coupling to downstream MAP kinase and 
phosphatidylinositol 3-kinase (PI-3K) effector pathways, were internalized normally in 
response to ligand (Fig. 5-1K and L). Thus, TrkA phosphorylation at Y794 and activation 
of PLCγ are selectively required for endocytosis in β-cells, as in neurons. 
 
Investigating the dynamics of NGF signaling pathways in β-cells 
 In order to better understand how TrkA influences insulin secretion in β-cells, we 
analyzed the kinetic responses of canonical neurotrophin signaling pathways in MIN6 cells 
treated with NGF. We found that NGF is capable of activating PI3K, MAPK, and PLCγ 
signaling pathways in MIN6 cells (Fig. 5-3A-F). While NGF elicited early and robust 
activation of ERK and PLCγ, p-AKT only showed significant phosphorylation after 1 hour 
of NGF stimulation. Interestingly CREB was also acutely activated within 10 minutes of 
NGF stimulation, which may contribute to the previous reports of pro-survival effects of 
neurotrophin signaling in β-cells. As activation of CREB is also known to stimulate MafA 
transcription to promote insulin production, future studies investigating the transcriptional 
effects of NGF on β-cells will be informative. In addition to acutely activating signaling 
effectors, TrkA in known to elicit prolonged signaling through the formation of signaling 
endosomes. One excellent example of this unique feature of TrkA signaling is the ability 
of TrkA, but not EGFR to activate the small GTPase Rap 1 in PC12 cells leading to 
continued MAP signaling up to an hour after stimulation (Wu et al., 2001). Given our 
findings that TrkA is internalized in β-cells, we tested that whether NGF could similarly 
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activate Rap1 in MIN6 cells. We found that indeed NGF activates Rap1 after one hour of 
treatment in MIN6 cells (Fig. 5-4A,B). This result differs somewhat from findings in PC12 
cells, however, in that activation is delayed and does not appear until 1 hour after 
stimulation, whereas NGF activates Rap1 robustly by 30 minutes in PC12 cells, perhaps 






















Figure 5-1: Glucose-induced actin changes and insulin secretion require TrkA 
endocytosis  
(A) NGF (100 ng/ml, 30 minutes) promotes internalization of TrkA receptors in MIN6 
cells. Membrane proteins were subjected to cell-surface biotinylation. Internalized TrkA 
receptors were detected by surface stripping of biotin, neutravidin precipitation, and TrkA 
immunoblotting. Supernatants were probed for p85 for normalization of protein amounts. 
(B) Densitometric quantification of internalized TrkA. Results are means ± SEM from 4 
experiments, **p<0.01, t-test (C,D) Trk receptors undergo ligand-dependent 
internalization in primary β-cells, assessed by a live cell antibody feeding assay. β-cells 
were infected with an adenovirus expressing FLAG-TrkB:A chimeric receptors. Infected 
cells were identified by co-expression of GFP, which is cytoplasmic. Cells were labeled 
with FLAG antibodies under non-permeabilizing conditions at 4°C for 30 minutes, 
followed by stimulation with BDNF (100 ng/ml) for 10 minutes. Ligand stimulation 
enhanced the intracellular accumulation of Trk receptors, monitored by FLAG 
immunoreactivity (in red). Internalized Trk receptors accumulated in early endosomes 
marked by EEA1 (in blue). Scale bar, 5 μm. (E) Ligand-mediated internalization of 
chimeric receptors into early endosomes was determined by assessing the co-localization 
of EEA1 immunofluorescence with that of FLAG. At least 10-20 cells were analyzed per 
condition per experiment. Results are means ± SEM from 3 independent experiments. 
**p<0.01, t-test. (F) TrkA endocytosis requires PLCγ activity but not calcineurin in β-cells. 
A cell surface biotinylation assay was used to follow NGF-dependent internalization of 
TrkA receptors in MIN6 cells in the presence or absence of the PLCγ inhibitor, U73122 or 
inhibitors of calcineurin, FK506 and cyclosporin A. Total surface TrkA levels available for 
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biotinylation are shown in the “no stripping” lane. Supernatants were probed for p85 for 
normalization. (G) Densitometric quantification of internalized TrkA after treatments as 
described in (F). Results are means ± SEM from 7 independent experiments. ***p<0.001, 
one way ANOVA followed by Tukey's post-test. (H-K) TrkA phosphorylation at Y794, 
the PLCγ docking site, is necessary for TrkA receptor endocytosis. Antibody feeding in 
MIN6 cells expressing FLAG-TrkA receptors shows that NGF-dependent receptor 
endocytosis is impaired by mutation of TrkA receptors at the PLCγ interaction site (Y794), 
but not Shc (Y499) binding site. Cells were labeled with FLAG antibodies under non-
permeabilizing conditions at 4°C for 30 min, followed by stimulation with NGF (100 
ng/ml) for 30 minutes. FLAG immunoreactivity is shown in red, and GFP, that was co-
transfected, in green. Scale bar, 5 μm. (L) Internal accumulation of FLAG-TrkA receptors 
under the various conditions was determined by assessing the proportion of co-localization 
of FLAG immunofluorescence with that of GFP, which is co-expressed and is cytoplasmic. 
At least 10-20 cells were analyzed per condition per experiment. Results are the mean ± 
SEM from 5 independent experiments. *p<0.05, one way ANOVA followed by Tukey's 
post-test. (M-Q) TrkA receptor endocytosis is required for glucose-induced actin changes 
in primary β-cells. Expression of wild-type FLAG-TrkA receptors corrects 1NMPP1-
mediated impairment of glucose-induced F-actin disassembly in isolated TrkAF592A β-cells. 
However, mutant FLAG-TrkAY794F receptors that are unable to undergo internalization, 
fail to rescue defects in glucose-induced actin reorganization in 1NMPP1-treated cells. 
Scale bar, 5 μm. Quantification shows average fluorescence intensity for F-actin labeled 
with phalloidin. Values are mean ± SEM from n=6 independent experiments, 20-25 cells 
were analyzed per condition per experiment. *p<0.05, **p<0.01, two-way ANOVA with 
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Bonferroni post-test. (R) TrkA receptor endocytosis is required for insulin secretion in 
islets. Expression of wild-type FLAG-TrkA, but not FLAG-TrkAY794F receptors, rescues 
the 1NMPP1-mediated impairment of glucose-stimulated insulin secretion in TrkAF592A 
islets. Values are mean ± SEM from n=5 independent experiments, ***p<0.001, n.s. not 







Figure 5-2: Adenoviral expression of FLAG-TrkA receptors, and role of PLCγ 
activity in insulin secretion  
(A) Doxycycline-induced expression of ectopic TrkA receptors in MIN6 cells infected with 
adenoviruses carrying FLAG-TrkAY794F or control FLAG-TrkA receptors. FLAG-tagged 
TrkA receptors appear on the cell surface as determined by a surface biotinylation assay. 
The FLAG immunoblot was stripped and reprobed for β-actin for normalization. (B) 
Glucose-stimulated insulin secretion is impaired in islets treated with a PLCγ inhibitor, 
U73122, compared to islets treated with an inactive analog, U73343. Values are means ± 
SEM from n=8 independent experiments, *p<0.05, ***p<0.001, n.s. not significant, two-






Figure 5-3: NGF activates TrkA and stimulates downstream signaling in MIN6 cells. 
(A) Equal numbers of MIN6 cells (passage 18-27) were incubated overnight in low serum 
and anti-NGF and the next day treated with either no ligand (time 0) or NGF (100 ng/mL) 
for 5, 10, 15, 30, or 60 minutes. Representative western blots are shown for p-TrkA, p-
PLCγ, p-AKT (S473), p-ERK1/2, and p-CREB (S133). (B) Quantifications of NGF 
stimulation are normalized to control (0 minutes). TrkA shows significant activation after 
10 and 30 minutes, 6.39±1.46 fold over 0 minutes, and 6.91±1.56 respectively. ERK1/2 is 
significantly activated after 5 and 60 minutes, 2.42±.68 and 2.56±0.53 respectively. AKT 
is activated 30 and 60 minutes after stimulation with NGF, 2.53±.50 and 2.94±0.62 
respectively, and levels of p-CREB are significantly elevated after 15 minutes, 3.62±1.35 
fold over time 0. Error bars represent means ± SEM, one-way ANOVA with Dunnett’s 












Figure 5-4: NGF activates Rap1 MIN6 cells. (A) Equal numbers of MIN6 cells (passage 
18-27) were incubated overnight in low serum and anti-NGF and the next day treated with 
either no ligand (time 0) or NGF (100 ng/mL) for 5, 10, 15, 30, or 60 minutes. 
Representative western blots are shown for Rap1-GTP. (B) Quantifications of NGF 
stimulation are normalized to control (0 minutes). TrkA shows significant activation after 















 In neurons, TrkA internalization in axon terminals, and subsequent endosomal 
signaling, is obligatory for long-distance communication between distal axons, the site of 
action of target-derived NGF, and neuronal cell bodies, as recently reviewed in (Cosker 
and Segal, 2014). In β-cells, TrkA endocytosis may allow access to intracellular signaling 
effectors including actin modulatory proteins, prolong receptor activation, or allow 
localized responses at specific sub-cellular domains (Sorkin and von Zastrow, 2009). 
Internalized TrkA endosomes could function to carry actin remodeling signals to the cell 
interior to promote the movement of insulin granules to the surface during the second phase 
of insulin secretion.  
 Interestingly, a recent study showed that β-cell specific deletion of dynamin 2 
results in a striking increase in F-actin density and impaired insulin secretion and glucose 
tolerance (Fan et al., 2015). Given our similar observations with TrkA inactivation, and the 
apparent calcineurin-dynamin 1 independence of TrkA internalization in β-cells, this raises 
the possibility that TrkA receptors may be a cargo for dynamin 2-mediated endocytosis in 
β-cells. Previous work has established that β-cells express both dynamin 1 and 2 (Lu et al., 
2008), however, a more extensive analysis of the specific isoforms of each dynamin variant 
will be important in determining the exact regulation of TrkA internalization in β-cells. 
 We found that, similar to NGF stimulation in neurons, TrkA signaling activates 
Rac1 however, TrkA may also associate with other actin remodelers. MAPK signaling 
originating from TrkA endosomes could also contribute to actin remodeling via an 
established role in promoting phosphorylation and activation of MLCK and MyoIIA 
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(Arous et al., 2013). While we have highlighted an acute role for TrkA signaling in GSIS, 
long-term signaling may have functions in transcriptional responses, proliferation, or 
survival of β-cells. Previous studies using neutralizing NGF antibodies, or pharmacological 
inhibition attenuated survival of rat β-cells in culture (Navarro-Tableros et al., 2004), while 
infusion of NGF increased islet mass and viability in transplanted islets in diabetic rats 
(Reimer et al., 2003) 
 This work focuses on the effect of TrkA signaling on actin remodeling via the 
formation of a signaling endosome however, we cannot rule out the possibility that TrkA 
signaling in β-cells mediates actin dynamics through PLCγ, independently of endocytosis. 
PLC signaling is known to promote exocytosis in chromaffin cells through the production 
of DAG that interacts with the priming factor Munc13-1, which is also important for 
sustained insulin secretion in β-cells (Bauer et al., 2007). PLC-mediated decreases in PIP2 
have been implicated in actin remodeling (Yamaga et al., 2015) and growth factor 
stimulation of PLC has been shown to activate cofilin in migrating carcinoma cells (van 
Rheenen et al., 2007). In this way, local and rapid TrkA activation of PLCγ may also 
directly contribute to the activation of gelsolin or insulin granule docking machinery 
proximal to the plasma membrane.  
 Although we have found an essential role for the TrkA-PLCγ signaling cascade in 
mediating actin remodeling, it is possible that TrkA-mediated activation of other pathways 
(namely MAPK, which has also been shown to be activated by phosphorylation on 
TrkAY794 (Stephens et al., 1994)) could augment signaling leading to actin remodeling in 
response to glucose. Recently the Src kinase, YES was shown to be activated at the plasma 
membrane in response to glucose (Yoder et al., 2014). Although there is no evidence yet 
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for TrkA interaction with this specific Src kinase, it has been shown that Src kinases can 
augment TrkA signaling in response to NGF (Tsuruda et al., 2004, Shi et al., 2010). 
Additionally, TrkA has been shown to interact with ephrinA5 in PC12 cells (Marler et al., 
2008), leading to the interesting possibility that TrkA could be involved in regulated 
EphA5/ephrinA5 signaling in β-cells which is known to be important for actin remodeling 
and insulin secretion (Konstantinova et al., 2007). Perhaps other glucose stimulated 
signaling effectors converge on TrkA signaling to help mediate the effects of NGF on TrkA 




















Mice and cell lines 
All procedures relating to animal care and treatment conformed to Johns Hopkins 
University Animal Care and Use Committee (ACUC) and NIH guidelines. Mice were 
housed in a standard 12:12 light-dark cycle. Mice were maintained on a C57BL/6 
background, or mixed C57BL/6 and 129P, or C57BL/6 and FVB backgrounds. Both sexes 
were used for analyses at 1-2 months of age, unless stated otherwise in the figure legends. 
TrkAF592A (TrkAf/f) mice were obtained from the Jackson Laboratory (Stock No: 022362).  
 
The MIN6 cell line was a generous gift from Dr. Jun-ichi Miyazaki (Osaka University) and 
Dr. Donald Steiner (University of Chicago). Cells between passage 12-30 were maintained 
in DMEM media plus 10% FBS, 5 U/L penicillin/5µg/L streptomycin, 200mM L-
glutamine, 100mM Sodium pyruvate, and 2μM β-mercaptoethanol. 
 
Antibodies 
Primary antibodies for immunofluorescence include guinea pig anti-insulin (1:300, abcam 
ab7842), mouse anti-EEA1 (1:500, BD Biosciences 610457). Rabbit anti-FLAG (1:100, 
Sigma Aldrich F7425) and mouse M2 anti-FLAG (1:100, Sigma Aldrich F3165) were used 
for live-cell antibody feeding assays. Fluorescent secondary antibodies were Alexafluor-




Primary antibodies for western blots include rabbit anti-phospho-AKT (S473) (1:1000 Cell 
Signaling 9271S), mouse anti-phospho-ERK1/2 (Thr202/Tyr204) (1:1000 Cell Signaling 
9106), rabbit anti-phospho-CREB (S133) (1:1000 Cell Signaling 9198), rabbit anti-PLCγ1 
(1:1000  Cell Signaling 2822), rabbit anti-TrkA (1:1000, Millipore 06-574), rabbit anti-
Rap1 (Millipore 07-916), rabbit anti-p85 (1:3000, Upstate Biotechnology 06-195), and 
rabbit anti-β-actin (1:1000, Cell Signaling, 4970) 
 
MIN6 cell NGF stimulation time course  
MIN6 cells were seeded at 0.8x106 cells/well in 6-well dishes and allowed to recover 
overnight. Following recovery, cells were starved in media containing 0.5% FBS. The next 
morning, cells were pre-incubated in DMEM without serum for 1 hour before stimulation 
with NGF (100ng/mL) for the indicated periods of time. The zero NGF control plate was 
maintained in DMEM without NGF for one hour. After incubation, cells were washed 
briefly with PBS and lysed with 500 µl RIPA buffer (50mM Tris-HCl, 150mM NaCl, ImM 
EDTA, 1% NP-40, 0.25% deoxycholate). For detection of p-TrkA and p-PLCγ, lysates 
were immunoprecipitated with 1:100 mouse anti-phospho-Tyrosine (clone PY20) and 1:10 
protein A beads (Santa-Cruz) rocking at 4ºC for 2 hours. Supernatants were collected for 
analysis of p-AKT, p-ERK1/2, p-CREB, and p85 for normalization of protein amounts. 
Beads were washed 3 times with RIPA before resuspension in 1x Laemmli buffer. Samples 
were boiled for 5 min prior to loading and SDS-PAGE analysis. Following transfer, 





For detection of active Rap1-GTP, cell lysates were immunoprecipitated using a Rap1 
activation assay kit (Millipore 17-321) according to the provider’s instructions. In brief, 
cells were lysed Rap1 activation lysis buffer, and lysates were incubated with Ral GDS-
RBD agarose beads for 1 hour at 4ºC with rocking. Supernatants were collected for protein 
normalization and beads were washed 3 times with lysis buffer and resuspended in 1X 
Laemmli buffer. Supernatant and precipitated samples were subjected to SDS-PAGE and 
following transfer, membranes were probed for Rap1, and β-actin for protein 
normalization. 
 
All immunoblots were visualized with ECL Plus Detection Reagent (Thermo Scientific, 
32132) and scanned with a Typhoon 9410 Variable Mode Imager (GE Healthcare). 
Densitometric analysis of bands was performed using ImageJ software. 
 
Plasmids and adenoviral vectors 
FLAG-TrkAY794F and FLAG-TrkAY499F constructs were generated by point mutations in a 
parent FLAG-TrkA vector (Bodmer et al., 2011), using QuikChange II XL site-directed 
mutagenesis kit (Agilent, #200521). Mutant plasmids were verified by DNA sequencing. 
Recombinant adenoviruses expressing FLAG-TrkA or FLAG-TrkAY794F were generated 
by sub-cloning FLAG-TrkA or FLAG-TrkAY794F from PCDNA3.1 into pAdenoX-Tet3G 
using the Adeno-XTM Adenoviral System 3 kit (Clontech). Recombinant adenoviral 
backbones were packaged into infectious adenoviral particles by transfection into HEK 
293 cells (ATCC) using Lipofectamine (Invitrogen). Generation of adenovirus expressing 
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chimeric FLAG-TrkB:TrkA receptors have been described previously (Ascano et al., 
2009). High-titer viral stocks were purified using a CsCl gradient. 
 
Islet isolations 
Islets were isolated as previously described (Wollheim et al., 1990). Briefly, pancreata 
collected from 1-2 month old mice were distended using collagenase (Collagenase P, 0.375 
mg/ml, Roche) dissolved in Hank’s Balanced Salt Solution (HBSS, Mediatech), and 
digested at 37°C. Digested pancreata were washed with HBSS, and subjected to 
discontinuous density gradient centrifugation using varying histopaque densities (Sigma-
Aldrich). The islet layer was collected, washed with HBSS, and islets handpicked under an 
inverted microscope for subsequent analyses. 
 
TrkA receptor internalization assays 
Cell surface biotinylation assays were performed in MIN6 cells as previously described 
(Kuruvilla et al., 2004). Briefly, MIN6 cells were biotinylated at 4ºC with a reversible 
membrane-impermeable form of biotin (EZ-Link™ NHS-SS-Biotin, 1.5mg/ml in PBS, 
ThermoFisher Scientific, Cat# 21441) for 25 minutes. For PLCγ inhibition, MIN6 cells 
were pre-treated for 30 minutes with U73122 (10 µM, Sigma Aldrich) or cyclosporine A 
and FK506 (2µg/mL/0.2µg/mL). Cells were washed briefly with PBS containing 50mM 
glycine (Sigma) to remove remaining unconjugated biotin, and then moved to 37ºC in 
DMEM containing 10% FBS and 5 U/l penicillin/streptomycin ± NGF (100ng/ml) for 30 
minutes to promote internalization. Cells were returned to 4ºC, the remaining biotinylated 
surface receptors were stripped of their biotin tag with 50mM glutathione (Sigma), 
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followed by two washes with 50mM iodoacetamide (Sigma) to quench excess glutathione. 
Cells were lysed with 500µl of RIPA buffer, and supernatants subjected to precipitation 
with 40µl-immobilized neutravidin agarose beads (ThermoFisher Scientific) and 
immunoblotted for TrkA.  
 
For expression analysis of the FLAG-TrkA control and FLAG-TrkAY794F receptors, 
MIN6 cells were infected with adeno-expressing FLAG-TrkA or FLAG-TrkAY794F 
viruses and induced with or without doxycycline (100 ng/ml) in RPMI 1640 media 
containing 5% FBS and 5 U/l penicillin/streptomycin for 24 hours. Cell surface 
biotinylation was performed as described above and cells were immediately washed with 
cold PBS and glycine, lysed with RIPA, and subjected to precipitation with neutravidin 
agarose beads. Supernatant and precipitated samples were subject to SDS-PAGE and 
probed for TrkA. 
 
Live cell antibody feeding assays were performed in dissociated β-cells and MIN6 cells as 
previously described (Ascano et al., 2009). βeta-cells were dissociated by gentle trituration 
in HBSS containing 4 mM EDTA, plated on poly-D lysine-coated coverslips, and 
transduced with an adenovirus expressing FLAG-TrkB:A chimeric receptors. Infected cells 
identified by GFP expression. Cells were rinsed briefly with PBS and incubated with rabbit 
anti-FLAG antibody (1:100) for 30 minutes at 4ºC, followed by a brief wash with cold 
PBS, and then stimulated with or without BDNF (100 ng/ml) in DMEM for 10 minutes at 
37ºC. Cells were quickly washed with PBS, fixed in 4%PFA/PBS for 30 minutes at room 
temperature, and permeabilized in 0.1% Triton X-100/1% BSA/PBS for 30 minutes at 
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room temperature. Immunostaining for insulin and EEA1 were performed overnight at 4ºC. 
Cells were washed in PBS and fluorescently conjugated secondary antibodies were applied 
for 1 hour at room temperature, washed again in PBS, and mounted on slides with 
Fluoromount. Images representing 1 μm optical slices were acquired using a Carl Zeiss 
LSM 510 confocal equipped with Confocor 3 Fluorescence Correlation Spectroscopy 
module, and argon (458–488 nm) and helium/neon (543–633) lasers. The same confocal 
acquisition settings were applied to all images taken from a single experiment. Threshold 
settings for blue and red scans were determined, and internalization was quantified as the 
ratio of anti-FLAG immunofluorescence (red) that colocalized with EEA1 (blue) relative 
to the total anti-FLAG immunofluorescence. Weighted coefficients of co-localization 
between the anti-FLAG and EEA1 fluorescence were determined by ImageJ software. 10-
20 cells were analyzed per condition per experiment. For antibody feeding assays in MIN6 
cells, cells were first transfected with plasmids carrying FLAG-TrkA, FLAG-TrkAY794F, 
or FLAG-TrkAY499F. GFP was co-transfected in all cases. Cells were stimulated with NGF 
for 30 minutes or left untreated in media alone. Internalization was quantified as the ratio 
of anti-FLAG immunofluorescence (red) that co-localized with cytoplasm (GFP signal) 
relative to the total anti-FLAG immunofluorescence for 10-15 cells per experiment. 
 
Phalloidin staining 
Islets were isolated from adult 1-2 month old TrkAF592A mice and dissociated into single 
cells by gentle trituration in HBSS containing 4 mM EDTA. Cells were resuspended in 
RPMI 1640 media containing 5% FBS and 5 U/l penicillin/streptomycin, and plated on 
glass coverslips coated with poly-D lysine. After 24 hours, islet cultures were treated with 
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1NMPP1 (20 µM) or DMSO for 20 minutes, followed by incubation in low (2.8 mM) or 
high (16.7 mM) glucose for another 30 minutes. Cells were fixed in 4% PFA and stained 
with Alexa546–conjugated phalloidin (Invitrogen). β-cells were identified by 
immunostaining for insulin. Images representing 1µm optical sections were acquired using 
a Zeiss LSM 510 confocal microscope. Average fluorescence intensities of Alexa-546 per 
μm2 in individual β-cells were measured using ImageJ software (NIH). 20-25 cells were 
analyzed per condition per experiment. 
 
To assess the effects of endocytosis-defective TrkA receptors on F-actin, isolated β-cells 
from TrkAF592A mice were incubated with adenoviruses expressing either FLAG-TrkAY794F 
or control FLAG-TrkA receptors, and treated with doxycycline (100 ng/ml) in RPMI 1640 
media containing 5% FBS and 5 U/l penicillin/streptomycin for 24 hours. β-cells were then 
incubated in 1NMPP1 (20μM) for 20 minutes to silence endogenous TrkA receptors, and 
then fixed and labeled with Alexa546–phalloidin as described above. 
 
In vitro GSIS assays 
To assess the effects of endocytosis-defective TrkA receptors on GSIS, TrkAF592A islets 
were incubated with high-titer adenoviruses expressing either FLAG-TrkAY794F or control 
FLAG-TrkA receptors, and treated with doxycycline (100 ng/ml, Sigma) in RPMI 1640 
media containing 5% FBS and 5 U/l penicillin/streptomycin for 30 hours. Islets were 
washed in Krebs-Ringer HEPES buffer (KRHB) containing low (2.8 mM) glucose and 
allowed to stabilize for 1 hour. Islets were then pre-incubated with 1NMPP1 (20µM) for 
20 minutes to silence endogenous TrkA592A receptors. Groups of 5-10 islets were then 
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handpicked into 24-well dishes and incubated in low (2.8 mM) or high glucose (16.7 mM) 
in KRHB buffer for another 30 minutes. Supernatant fractions were removed, the islets 
were lysed in acid ethanol, followed by insulin ELISA (Crystal Chem) to determine the 


























CHAPTER 6. GLUCOSE DEPENDENT REGULATION OF NGF SECRETION 
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Extrinsic regulators of insulin secretion 
 Although loss of β-cell function precedes a reduction in β-cell mass during the 
development of diabetes (Defronzo, 2009, Weir and Bonner-Weir, 2004), research has 
predominantly focused on mechanisms governing β-cell proliferation (Vetere et al., 2014, 
Wang et al., 2015, Stewart et al., 2015), and far less is known about extrinsic factors that 
influence GSIS. While glucose is the primary and most potent stimulator of insulin 
secretion, neurotransmitters (Woods and Porte, 1974, Ahrén et al., 2006) and incretins 
(Drucker, 2006) also have well-established roles as insulin secretagogues. They influence 
GSIS by generating second messengers that impinge on β-cell electrical activity and/or 
insulin exocytosis (Ahrén et al., 2006, Nakazaki et al., 2002, Drucker, 2006).  
 Some nutrient-derived factors, such as amino acids and fatty acids, are metabolized 
by β-cells and stimulate ATP production to augment insulin secretion (McClenaghan et al., 
1996, Roduit et al., 2004, Prentki et al., 1992). Recently, many of these same nutrients have 
also been found to potentiate insulin secretion by acting directly on G-protein coupled 
receptors (GPCRs) on β-cells to increase intracellular calcium (Pi et al., 2012, Itoh et al., 
2003, Briscoe et al., 2003). Perhaps the most well characterized insulin regulators are 
metabolic hormones known as incretins, namely glucagon-like peptide-1 (GLP-1) and 
gastric inhibitory peptide (GIP), which are secreted by L- and K-intestinal cells 
respectively. These peptide hormones act through GPCRs to increase intracellular cAMP 
in pancreatic β-cells resulting in the activation of PKA and Epac2 (Holz, 2004, Drucker, 
2006) which modulate intracellular calcium (Kang et al., 2005), closure of KATP channels 
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(Nakazaki et al., 2002), and phosphorylation of granule fusion machinery including Snapin 
and synaptogamin-7(Wu et al., 2015, Song et al., 2011) The overall effect of incretins on 
these regulators of insulin secretion is to increase the pool of readily releasable granules to 
enhance secretion upon stimulation (Wan et al., 2004, Shibasaki et al., 2007). Beyond their 
insulinotropic effects, incretins also regulate transcription via activation of cyclic response 
element binding protein (CREB) which promotes β-cell survival (Kim et al., 2005, Kim et 
al., 2008) and proliferation (Buteau et al., 2003, Xu et al., 1999).  
 Given the potency of insulin signaling, it is not surprising that many insulin 
secretagogues are themselves precisely regulated by nutrient intake to protect against 
hypoglycemia and ensure that insulin secretion in vivo remains glucose-dependent at much 
lower glucose concentrations than are effective in vitro (Henquin et al., 2003). Vagal 
activity during the meal anticipatory “cephalic phase” of insulin secretion leads to 
increased secretion of gastrin, ghrelin, and GLP-1, as well as insulin to help prime the body 
for optimum nutrient absorption and maintenance of glucose homeostasis (Power and 
Schulkin, 2008). Following meal consumption, an even greater increase in circulating 
levels of many enzymes and metabolic hormones is observed (Begg and Woods, 2013). 
These signals come predominantly from the gastrointestinal tract and influence meal size 
by producing signals that act either indirectly through the vagal pathway, or directly by 
activating receptors in the brain (Begg and Woods, 2013). In addition to incretin hormones, 
decretins such as neuromedin U and galanin, help keep insulin secretion low during periods 
of nutrient deprivation (Hussain et al., 2016). Signaling from the liver and adipose tissue, 
via kisspeptin and leptin respectively, can also impair GSIS when there is excessive 
nutrient intake. Stress and inflammatory factors, such as IL-6 and TNF, are known to 
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influence both food intake and the production of incretins, which likely contribute to 
aberrant regulation of insulin secretion in diseased states (Ellingsgaard et al., 2011, Zietek 
and Rath, 2016). 
 
Neurotrophins in metabolism and energy homeostasis 
 Neurotrophins have been best studied for their influence on neuronal development, 
however, they have also been found to play important roles in the regulation of feeding and 
metabolism. Perhaps the most extensively characterized neurotrophin in metabolic 
function is BDNF. Recent data has highlighted the importance of BDNF both within 
several nuclei of the hypothalamus that are responsible for regulating appetite and energy 
balance as well as in the periphery within glucagon secreting alpha cells. Loss of BDNF or 
TrkB in mice has been shown to result in hyperphagia, obesity, and increased anxiety (Rios 
et al., 2001, Kernie et al., 2000, Yang et al., 2016, Xu et al., 2003). Conversely, 
administration of BDNF reduces food intake and lowers blood glucose levels in mouse 
models of obesity and diabetes (Ono et al., 1997, Tonra et al., 1999). In clinical studies in 
humans, plasma levels of BDNF are found reduced in cases of atherosclerosis, metabolic 
syndrome, and type two diabetes (Manni et al., 2005, Boyuk et al., 2014, Civelek et al., 
2013, Suwa et al., 2006, Chaldakov et al., 2004).  
 Both expression of BDNF and its high affinity receptor, TrkB are enriched in 
several regions of the hypothalamus in the adult brain, including the ventromedial (VMH), 
arcuate (ARC), paraventricular (PVN) nuclei, that are key regulators of energy homeostasis 
and feeding behavior (Yang et al., 2016, An et al., 2015, Xu et al., 2003). In the VMH, 
BDNF expression is regulated by the melanocortin-4 receptor activity in response to 
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nutritional state. Under fasting conditions and low nutrient availability, MC4R activity and 
BDNF expression are repressed, but in response to feeding or stimulation with a MC4R 
agonist, BDNF levels increase. Interestingly, the specific effect of BDNF on lowering 
blood glucose levels was shown to be independent of the reduction in food intake by 
eloquent paired-feeding experiments (Nakagawa et al., 2000, Yamanaka et al., 2006, 
Coppola and Tessarollo, 2004). Experiments to determine how BDNF might regulate 
glucose homeostasis revealed that BDNF had no influence on insulin levels. Rather, BDNF 
was found to decrease the concentration of circulating glucagon, thus inhibiting aberrant 
glucose mobilization (Yamanaka et al., 2006, Hanyu et al., 2003). TrkB immunoreactivity 
is present in alpha cells in the mantle of murine islets, but not in the core occupied by β-
cells (Hanyu et al., 2003). Furthermore, administration of BDNF in isolated islets 
decreased glucagon secretion. In addition to directly modulating alpha-cell activity, BDNF 
signaling through TrkB in adipocytes may regulate transcriptional regulation of 
“browning” of white fat (Cao et al., 2011).  
 Although the effects of BDNF/TrkB signaling on regulation of energy homeostasis 
and feeding have been extensively studied, less is known about the involvement of other 
neurotrophins in metabolic control. Despite this paucity of information, studies have 
revealed potential metabolic roles for ciliary neurotrophic factor (CNTF) and NGF. 
Originally identified as a factor necessary for the survival of ciliary ganglion cells, CNTF 
was found to promote neurogenesis in POMC expressing neurons and inhibit the 
expression of orexigenic NPY in the hypothalamus (Kokoeva et al., 2005). In the periphery, 
there is evidence that CNTF can act on skeletal muscle, brown fat, and the liver to increase 
fatty acid oxidation, upregulate makers of brown fat, and improve insulin sensitivity. In 
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animal models CNTF was shown to improve symptoms associated with obesity and 
diabetes (Liu et al., 2007, Gloaguen et al., 1997).  The clinical relevance of these findings 
was exemplified by the observed improvement in hyperglycemia, hyperinsulinemia, and 
hyperlipidemia in obese individuals treated with a human recombinant variant of CNTF 
(Axokine®) (Ettinger et al., 2003).  
 Dysregulation of NGF has also been observed in patients diagnosed with 
atherosclerosis, metabolic syndrome, and diabetes (Manni et al., 2005, Civelek et al., 2013, 
Bullo et al., 2007, Chaldakov et al., 2004, Anand et al., 1996). During the initial stages of 
metabolic syndrome, it has been hypothesized that the interplay of cytokines and 
neurotrophins leads to hyper-activation of the autonomic nervous system resulting in 
eventual hormonal imbalance and peripheral leptin and insulin insensitivity (Hristova and 
Aloe, 2006). Indeed, NGF has been documented to activate the pituitary-adrenocortical 
axis in response to stress resulting in increased circulating glucocorticoids (Otten et al., 
1979, Taglialatela et al., 1991). Once metabolic syndrome is fully manifested, a decrease 
in plasma levels of neurotrophins is observed (Chaldakov et al., 2001, Chaldakov et al., 
2004, Hristova and Aloe, 2006). Together these studies highlight the importance of 










 Alterations in NGF levels have been noted in serum, nerves, and peripheral tissues 
in diabetic humans and animal models (Bullo et al., 2007) (Bullo et al., 2007, Kim et al., 
2009, Meloni et al., 2010). Additionally, elevated glucose enhances NGF biosynthesis and 
secretion in cultured rat β-cells (Rosenbaum et al., 1998). These results, together with the 
observed expression patterns of NGF and TrkA in the pancreas, prompted us to ask if the 
NGF signaling pathway might be regulated by glucose in vivo. To address this question, 
we measured serum NGF levels in mice that were fasted overnight and subjected to a 
glucose challenge administered intra-peritoneally. We observed a significant elevation in 
circulating NGF levels within 15 minutes of the glucose challenge (Fig. 6-1A), suggesting 
that NGF secretion is acutely regulated by glucose in vivo.  
 To determine if glucose influences TrkA activity, we assessed TrkA 
phosphorylation in isolated islets treated with high glucose (16.7mM). 15 minutes of 
exposure to elevated glucose stimulated a robust increase (11.69 ± 1.9-fold) in islet TrkA 
phosphorylation levels, compared to basal conditions (2.8 mM glucose) (Fig. 6-2A,B). 
Together, these findings indicate that NGF secretion and signaling in pancreatic islets are 
regulated by glucose, and suggest an instructive role for the NGF pathway in facilitating 
GSIS.  
  
Glucose dependent NGF-TrkA signaling in human islets 
 Basic research performed in rodent model systems has yielded significant insights 
into the mechanisms and key regulatory pathways involved in GSIS in humans, however, 
as with any model system, there are limits to the parallels that can be drawn between 
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processes occurring in one organism versus the other. Recent studies have begun to 
highlight structural, transcriptional, and functional differences between human and rodent 
islets (Jiao et al., 2014, Cabrera et al., 2006, Benner et al., 2014, MacDonald et al., 2011). 
These results demonstrate the importance of determining the relevance of findings in 
mouse models in a human system. The advent of organizations that improve the 
accessibility and distribution of human islets to investigators (such as the Integrated Islet 
Distribution Program-IIDP in the U.S.A.) (Kulkarni and Stewart, 2014, Kaddis et al., 
2009), and techniques for generating β-cells from induced pluripotent stem cells (Hua et 
al., 2013) has made it more feasible to make the needed comparisons. We acquired human 
islets from the IIDP from 6 healthy individuals of both sexes between the ages of 33 and 
59 and 3 and pre-diabetic individuals, and tested the effect of glucose on TrkA activity and 
GSIS. Similar to our findings in mouse islets, we see significant enhancement of TrkA 
phosphorylation in human islets in response to an acute elevation in glucose (Fig. 6-3A,B). 
Although the level of stimulation of p-TrkA is not as great in human islets, human islets 
were maintained under culture conditions for several days as opposed to overnight 
culturing in mouse islets. It is possible that relevant cell types that produce NGF in human 
islets may be compromised by this prolonged period of culturing, thus affecting the level 
of stimulation in response to glucose. Interestingly, stimulation with high glucose in islets 
from pre-diabetic individuals had no effect on p-TrkA levels, implying that TrkA signaling 
is affected in a diseased state. Since pre-diabetic individuals are defined by having higher 
than normal blood glucose levels, but are not overtly diabetic, impaired neurotrophin 
function may be an early indicator of reduced β-cell function. Additionally, we found that 
NGF treatment augmented GSIS in human islets, but basal insulin secretion was unaffected 
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(Figure 6-1G). These results support a physiological role for NGF in potentiating GSIS, 
























Figure 6-1: Glucose regulates NGF secretion from smooth muscle cells 
(A) Circulating NGF levels are rapidly increased 15 minutes after a glucose injection (2 
g/kg body weight, i.p.) in mice. Mice were fasted overnight prior to the glucose challenge. 
NGF levels were measured by ELISA, from tail vein blood drawn before and 15 minutes 
after glucose administration. Values are the mean ± SEM from n=14 mice, *p<0.05, paired 
two-tailed t-test. (B) Cultured aortic smooth muscle (P3) secretes NGF in response to 












Figure 6-2: Elevated glucose stimulates acute phosphorylation of TrkA in islets 
(A) High glucose stimulation (16.7 mM, 15 minutes) elicits a marked increase in 
phosphorylated TrkA levels in isolated islets, compared to low glucose (2.8 mM). Islet 
lysates were immunoblotted with a phospho-TrkA antibody, and then stripped and re-
probed for TrkA for normalization. (B) Densitometric quantification of phospho-TrkA 
levels normalized to total TrkA levels. Values are the mean ± SEM from n=3 independent 










Figure 6-3: Glucose mediated activation of TrkA has implications in human islet 
function 
(A,B) High glucose stimulation (16.7 mM, 15 minutes) induces increased phosphorylation 
of TrkA in healthy, but not pre-diabetic human islets. Islet lysates were immunoblotted 
with a phospho-TrkA antibody, and then stripped and re-probed for TrkA for 
normalization. Values are the mean ± SEM for n=6 non-diabetic and n=3 pre-diabetic 
individuals. ∗p<0.05, two-way ANOVA with Bonferroni post-test. (C) Islets from healthy 
individuals demonstrate increased GSIS in the presence of NGF (100ng/mL) (3.28 ± 0.50 
fold increase over basal glucose) versus the absence (2.04 ± 0.32) n=7 individuals . 



















 While glucose has the unique ability to trigger insulin secretion, a number of 
extrinsic signals enhance the secretory capacity of β-cells (Henquin et al., 2003). These 
extrinsic factors, including intestinal hormones and nutrients, are systemically delivered 
via the bloodstream to islets (Caicedo, 2013). Other than neurotransmitters derived from 
nerve terminals or islet cells (Caicedo, 2013), relatively little is known about factors that 
locally influence β-cell secretory function. 
 This work revealed an unexpected physiological cross-talk between nutrient and 
neurotrophin signaling. Elevated glucose rapidly increased NGF secretion in vivo, and 
profoundly enhanced TrkA phosphorylation in islets. These results argue against a merely 
permissive role for NGF signaling in glucose-stimulated insulin secretion, and suggest an 
instructive mechanism by which glucose recruits the NGF signaling axis to augment insulin 
secretion. This is similar to the effects of glucose on intestinal hormones and 
neurotransmitters that subsequently act in concert to tightly regulate a post-prandial insulin 
secretory response. Future studies will be of interest in elucidating the glucose sensing and 
signaling mechanisms that underlie glucose-mediated neurotrophin secretion in pancreatic 
vascular cells.  
 Interestingly, we provide data that highlights the relevance of neurotrophin 
signaling in human islets, and further suggest that this signaling may be affected in a 
diseased state. Our preliminary findings from 3 pre-diabetic individuals shows 
significantly reduced neurotrophin signaling, indicating that impaired TrkA signaling or 
reduced NGF secretion may be an early indicator of diabetes. In the future, it will be 
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important to increase our sample size of pre-diabetic individuals and perhaps investigate 
the state of neurotrophin signaling in overtly diabetic individuals. We would also like to 
determine how NGF secretion from islets is altered both in rodent models of obesity and 
diabetes, as well as in pre-diabetic and diabetic human islets. These investigations should 
greatly enhance our understanding of how NGF participates in GSIS and the progression 























All procedures relating to animal care and treatment conformed to Johns Hopkins 
University Animal Care and Use Committee (ACUC) and NIH guidelines. Mice were 
housed in a standard 12:12 light-dark cycle. Mice were maintained on a C57BL/6 
background, or mixed C57BL/6 and 129P, or C57BL/6 and FVB backgrounds. Both sexes 
were used for analyses at 1-2 months of age, unless stated otherwise in the figure legends. 
TrkAF592A (TrkAf/f) mice were obtained from the Jackson Laboratory (Stock No: 022362)  
 
Human islets 
We obtained human islets via the NIDDK–supported Integrated Islet Distribution Program 
(IIDP) from the Southern California-Islet Cell Resource Center, Scharp/Lacy Institute, 
University of Miami, and University of Wisconsin. Islet were obtained from 10 healthy 
donors (5 females, 5 males), ranging in age from 22-59 years with BMI values between 
22.7 and 34.8. Islets from 3 pre-diabetic individuals (males ages 57-62, BMI 23-30.6) were 
also obtained. The Johns Hopkins Institutional Review Board declared the human islet 






Primary antibodies for western blots include rabbit anti-Phospho-TrkA (Tyr785)/TrkB 
(Tyr816) (1:1000, Cell Signaling C67C8), rabbit anti-TrkA (1:1000, Millipore 06-574), 
and abbit anti-β-actin (1:1000, Cell Signaling, 4970). 
 
Immunoblotting 
For detection of phosphorylated TrkA, isolated islets were allowed to recover overnight in 
RPMI 1640 medium containing 5% fetal bovine serum (FBS) and 5 U/L penicillin/5µg/L 
streptomycin (for mouse islets) or CMRL 1066 medium containing 10% human serum 
albumin, 5 U/L penicillin/5µg/L streptomycin, 2mM GlutaMAX, and 1mM sodium 
pyruvate (for human islets). Islets were pre-incubated in Krebs-Ringer HEPES buffer 
(KRHB) containing low (2.8 mM) glucose for 1 hour, and then either left in 2.8 mM 
glucose or stimulated with 16.7 mM glucose in KRHB buffer for 15 minutes, and lysates 
prepared in boiling Laemmli buffer. Lysates were subjected to immunoblotting with rabbit 
anti-Phospho-TrkA (Tyr785)/TrkB (Tyr816), and membranes were later re-probed for 
rabbit anti-TrkA. All immunoblots were visualized with ECL Plus Detection Reagent 
(Thermo Scientific, 32132) and scanned with a Typhoon 9410 Variable Mode Imager (GE 
Healthcare). Densitometric analysis of bands was performed using ImageJ software. 
 
In vivo and in vitro analyses of secreted NGF 
For in vivo NGF secretion assays, mice were fasted overnight before being injected with 
glucose (3 g/kg, i.p.). Blood was collected from the tail at the times indicated, spun down, 
and the resulting plasma fractions subjected to NGF ELISA (Millipore, CYT304). 




For in vitro NGF secretion assays, primary aortic vascular smooth muscle cell cultures 
were established as previously described (Metz et al., 2012). Wildtype mice, 1-2 months 
of age, were euthanized and the aorta was dissected, de-endothelialized, and cut into small 
(~1mm x 1mm) squares. The squares were pressed lumen side down on a collagen-coated 
dish and allowed to adhere for 15-30 minutes before the addition of fresh media (DMEM 
media plus 20% FBS, 5 U/L penicillin/5µg/L streptomycin, 2mM GlutaMAX, and 1mM 
sodium pyruvate). Smooth muscle cells were allowed to migrate out of the explants and 
proliferate for 5 days before passaging. After the third passage in culture, smooth muscle 
cells were plated in 6cm dishes and allowed to grow to confluency for 3 days. Cells were 
equilibrated in Krebs-Ringer HEPES buffer (KRHB) containing low (2.8 mM) glucose for 
40 minutes, and then 3mL of fresh Krebs-Ringer HEPES buffer with 2.8 mM glucose was 
added for 15 minutes and collected before the addition of 3mL Krebs-Ringer HEPES buffer 
with 16.7 mM glucose for 15 minutes. Supernatants (2.8 and 16.7mM glucose Krebs-
Ringer HEPES buffer) were concentrated to 100µl using Amicon Ultracel 3K filter devices 
(Millipore) and cells were lysed with RIPA before being subjected to quantification with 
NGF ELISA (Millipore). 
 
In vitro GSIS assays 
Human islets to recover overnight in CMRL 1066 medium containing 10% human serum 
albumin, 5 U/L penicillin/5µg/L streptomycin, 2mM GlutaMAX, and 1mM sodium 
pyruvate. Islets were washed in Krebs-Ringer HEPES buffer (KRHB) containing low (2.8 
mM) glucose and allowed to stabilize for 1 hour. Groups of 5-10 islets were then 
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handpicked into 24-well dishes and incubated in low (2.8 mM) or high glucose (16.7 mM) 
in KRHB buffer with vehicle or NGF (100ng/mL) for another 30 minutes. Supernatant 
fractions were removed, the islets were lysed in acid ethanol, followed by insulin ELISA 
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 We have revealed a mechanism by which neurotrophin signaling directly influences 
endocrine functions. Our findings suggest a feed-forward model whereby NGF, secreted 
by the pancreatic vasculature in response to glucose, activates β-cell TrkA receptors to 
acutely promote glucose-stimulated insulin secretion (Figure 7). TrkA signaling, 
specifically by internalized receptors, overcomes a peripheral F-actin barrier to boost 
insulin granule exocytosis in β-cells. Together, these findings identify a new regulatory 
pathway essential for insulin secretion and blood glucose homeostasis. 
 
Neurotrophin signaling and effects outside the nervous system 
 To date, neurotrophins have been best-studied as essential regulators of neuronal 
development and neurotransmission in the vertebrate nervous system (Huang and 
Reichardt, 2001b). All understanding of neurotrophin signaling mechanisms has been 
gleaned from work in neurons. Although neurotrophins have an indisputably central role 
in neuronal development, the Trk family of receptors has been found to be expressed 
broadly outside of the nervous system. NGF and TrkA have been shown to function in 
several immune cell types (Aloe et al., 1997, Mazurek et al., 1986, Coppola et al., 2004, 
Brodie and Gelfand, 1994), the pancreas, reproductive organs (Mayerhofer et al., 1996, Li 
and Zhou, 2013, Jin et al., 2010), vasculature (Donovan et al., 1995, Khan et al., 2002, 
Nico et al., 2008), and kidneys (Shibayama and Koizumi, 1996, Sariola, 2001, Kapuscinski 
et al., 1996).  
 NGF neutralizing antibodies and the selective pharmacological inhibitor of tyrosine 
kinases, K252a, have allowed for some mechanistic understanding of neurotrophin 
signaling in non-neuronal cells types. However, there is limited in vivo evidence for the 
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specific roles of Trk receptors outside the nervous system. This deficit in data is due, in 
part, to the early lethality of mice with a global loss of TrkA, as well as the possible indirect 
consequences of loss of TrkA in the nervous system on any phenotype outside the nervous 
system. Our understanding of non-neuronal neurotrophin signaling would greatly benefit 
from in-depth, tissue-specific approaches to target Trk signaling within precise cell 
populations. We took advantage of recent advances in the diversity and availability of 
conditional mouse lines to determine where and how NGF and TrkA are functioning in the 
pancreas. Given the existing reports of TrkC expression in β-cells (Tazi et al., 1996) and 
TrkB expression in alpha-cells(Hanyu et al., 2003), similar approaches using reporter 
mouse lines for BDNF and NT-3 as well as conditional mouse lines for TrkB and TrkC 
will facilitate a better understanding of how other neurotrophins could contribute to 
metabolic homeostasis.  
 
Neuronal factors in insulin secretion 
 Although neurons and β-cells have distinct developmental origins (Pictet et al., 
1976, Fontaine and Le Douarin, 1977), they share remarkable similarities in terms of 
electrical properties, ion channel composition, and exocytic machinery involved in 
regulated secretion (Arntfield and van der Kooy, 2011). Recent reports have highlighted 
pleiotropic roles for well-established neurotransmitters and axon guidance factors in 
regulated insulin secretion. Intra-islet secretion of neuropeptide W (NPW) and pituitary 
adenylate cyclase-activating protein (PACAP) have both been shown to activate G-protein 
coupled receptors on β-cells resulting in increased [Ca2+]i and potentiated GSIS (Dezaki 
et al., 2008, Yada et al., 1997). Axon guidance factors including intra-islet netrin and SLIT 
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have been implicated in β-cell survival (Yang et al., 2011, Yang et al., 2013). In addition 
to β-cell survival, SLIT was also found to act through canonical ROBO receptors to 
regulate ER Ca2+ release and actin remodeling (Yang et al., 2013). Similarly,  Rac1, a 
key actin regulatory protein in β-cells, was identified as a target of EphA/ephrin-A 
signaling in GSIS in β-cells (Konstantinova et al., 2007). These results demonstrate the 
importance of neuronal and paracrine factors in β-cell function. In this study, we describe 
a non-canonical role for neurotrophins outside of the nervous system, and also define a 
conserved mechanism for neurotrophin actions via signaling endosomes in non-polarized 
β-cells. We further demonstrated a conserved mechanism in which TrkA must undergo 
endocytosis and activate Rac1 in order to influence actin remodeling in response to glucose 
to allow for proper insulin granule secretion. 
 
The actin cytoskeleton as a regulator of insulin secretion 
 The cytoskeleton is often regarded as a static structure that maintains the shape and 
integrity of the cell, however elements of the cytoskeleton can be quite dynamic. 
Microtubules and actin are key components of regulated signaling and secretory events 
(Gasman et al., 2004). Tubulin subunits, alpha- and beta-tubulin, comprise microtubules 
that form tracks along which kinesin and dynein motor proteins carry cargo such as 
organelles and secretory vesicles. Monomers of G-actin bind together to form filaments of 
F-actin upon which myosin motors move cargo and generate the tension needed for muscle 
contraction. The dynamic nature of “tread-milling” actin filaments is also key to the 
process of cell migration and endocytic events. 
133 
 
 Microtubules have been shown to be important for the maintaining the structure of 
the Golgi complex that is itself a central structure in secretory vesicle maturation and 
movement. In the liver, microtubules are essential for lipoprotein secretion (Orci et al., 
1973, Reaven and Reaven, 1980) and alcohol-induced alterations in microtubule structure 
and stability are thought to underlie reduced hepatic protein and membrane trafficking in 
alcoholism (Joseph et al., 2008). In addition to facilitating constitutive trafficking of cargo, 
recent work has also demonstrated a role for microtubule dynamics in insulin granule 
release. Hoboth et al. first demonstrated that “old” insulin granules lose their propensity to 
associate with microtubules and become restricted in multi-vesicular bodies destined for 
degradation (Hoboth et al., 2015). Zhu and colleagues further showed that microtubules in 
β-cells are organized into a dense meshwork rather than radial arrays extending from the 
cell center (Zhu et al., 2015). This dense network of microtubules restricts the mobility of 
insulin granules under basal conditions but, upon glucose stimulation, both microtubule 
depolymerization and nucleation in the Golgi result in larger “openings between filaments 
and increasing the availability of granules for secretion. 
 Although there is emerging evidence for microtubule involvement in regulating 
insulin secretion, a far greater body of research exists that supports a central role for actin 
dynamics in insulin secretion. Results have indicated both negative and positive roles for 
the actin cytoskeleton in secretory granule release. Early ultra-structural analysis of 
secretory cells indicated the presence of a cortical web of dense actin just beneath the 
plasma membrane that restricts granule access to the cell surface (Orci et al., 1972). F-actin 
dynamics have since been shown to be important for exocytosis in chromaffin cells (Vitale 
et al., 1995), adipocytes (Omata et al., 2000), endothelial cells (Wang et al., 2010), β-cells 
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(Kalwat and Thurmond, 2013), acinar cells (Valentijn et al., 1999), neurons (Morales et 
al., 2000), and mast cells (Wollman and Meyer, 2012). Stimulus-induced secretion can be 
enhanced by a number of pharmacological agents that depolymerize actin, such as 
cytochalasins and latrunculin toxins (Henquin et al., 2012, Li et al., 1994, Kalwat and 
Thurmond, 2013). Combined with structural analysis indicated granule exclusion from the 
cell periphery in basal conditions, these data provided strong evidence for a negative role 
for F-actin in secretion. However, these results must be tempered by opposing data 
indicating a requirement for actin filaments in sustained secretion (Kalwat and Thurmond, 
2013, Uenishi et al., 2013, Varadi et al., 2005). Just as the role of microtubules in insulin 
secretion requires a balance between nucleation and depolymerization, actin changes in 
response to elevated glucose likely involve “remodeling” rather than strict 
deploymerization or stabilization during secretion. 
 The primary regulators of actin remodeling in β-cells are the Rho family of small 
GTPases, in particular Cdc42 and Rac1 (Kalwat and Thurmond, 2013, Wang et al., 2011, 
Nevins and Thurmond, 2003). Glucose activates Cdc42 within the first 2-3 minutes of a 
glucose challenge and subsequently stimulates the downstream effector, p21-associated 
kinase (PAK1) that is responsible for activating Rac1 (Nevins and Thurmond, 2003, Wang 
et al., 2011, Kalwat et al., 2013). PAK1 knockout mice are glucose intolerant and have a 
significantly impaired second phase of insulin secretion (Wang et al., 2011). Notably, 
patients with type 2 diabetes have been reported to have about an 80% reduction in PAK1 
levels (Wang et al., 2011). β-cell specific loss of Rac1 or expression of dominant negative 
Rac1 results in similar defects in second phase insulin secretion (Asahara et al., 2013, 
Kowluru, 2011). Besides Rac1, PAK1 is also known to directly and indirectly activate 
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other actin regulators including cofilin, gelsolin, filamin A, and focal adhesion kinase 
(FAK) (Kalwat and Thurmond, 2013). Upon glucose stimulation, intracellular signaling 
through β1-integrin leads to phosphorylation of FAK and paxillin which additionally 
activate MAPK signaling and cytoskeletal remodeling (Cai et al., 2012, Rondas et al., 
2011). Additional actin associated proteins whose activity can be modulated by glucose 
include N-WASP and Arp2/3, which promote actin polymerization, and scinderin that 
severs actin filaments in response to calcium (Uenishi et al., 2013).  
 β-cells have many molecular and physical properties in common with neurons, not 
least of which is stimulus-coupled secretion of vesicles. Once insulin granules arrive at the 
plasma membrane, calcium is required to for the final activation of the fusion machinery 
responsible for vesicle exocytosis. Soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) proteins have been extensively studied in the context of synaptic 
transmission, and can be generally divided into two classes, v-SNAREs that associate with 
vesicles, and t-SNARES that are found on the plasma membrane. In response to a stimulus, 
the v-SNARE, VAMP is guided to associate with the t-SNARES, syntaxin and SNAP. β-
cells express several different syntaxin and SNAP isoforms which appear to function 
during different phases of insulin secretion (Bronk et al., 2007, Wang and Thurmond, 2009, 
Kalwat and Thurmond, 2013, Kalwat et al., 2012, Song et al., 2011). Syntaxin-1 and SNAP 
25 are known to interact with both voltage gated calcium channels as well as potassium 
channels and are important for the first phase of insulin secretion (Ostenson et al., 2006). 
In contrast, syntaxin-4 has been implicated in regulating both first and second phase insulin 
secretion (Kalwat and Thurmond, 2013), and is known to bind filamentous actin and the 
calcium dependent actin remodeler, gelsolin (Kalwat et al., 2012). F-actin binds syntaxin-
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4 at the N-terminus and may physically block incoming VAMP2 containing insulin 
granules from aberrantly fusing with the plasma membrane under basal glucose conditions 
(Jewell et al., 2008, Ostenson et al., 2006, Kalwat et al., 2012). Glucose stimulation results 
in dissociation of syntaxin-4 and F-actin and allows association with incoming insulin 
granules (Jewell et al., 2008). Additionally, syntaxin-4 interacts with gelsolin in a calcium 
dependent manner (Kalwat et al., 2012). Upon depolarization, and the subsequent increase 
in intracellular calcium, gelsolin loses its association with syntaxin-4 and becomes 
activated, perhaps clearing the way for insulin granule recruitment.   
 Although many glucose stimulated actin modulators in β-cells have been identified, 
the upstream molecular players that are directly activated by glucose have yet to be 
determined. Interestingly, there are examples of tyrosine kinase mediated actin remodeling 
in response to glucose. The Src family tyrosine kinase, YES was recently shown to localize 
to the plasma membrane in β-cells and is phosphorylated in a glucose dependent manner 
(Yoder et al., 2014). Additionally, EphA5/ephrin-A5 forward signaling is important for 
keeping insulin secretion low under basal glucose conditions, while elevated glucose 
triggers stimulation of reverse ephrin-A5 signaling to activate Rac1 and increase insulin 
secretion (Konstantinova et al., 2007). 
 
NGF as a potential therapeutic agent for metabolic disorders 
 Early research investigating the influence of NGF on the pancreas revolved around 
its use as a potential therapy for the treatment of diabetic neuropathy (Pittenger and Vinik, 
2003, Anand et al., 1996). Remarkably, NGF was one of the first growth factors to proceed 
to clinical trials, however issues with experimental design including variation in treatment 
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groups and dosage of NGF prevented further progress in its development as a viable 
therapeutic agent (Apfel, 2002). Additional studies in vitro suggest that NGF may have a 
direct influence on β-cell electrical potential resulting in potentiation of insulin secretion 
(Rosenbaum et al., 2002). Recent work has also evaluated the influence of NGF on islet 
transplantation (Miao et al., 2006, Hata et al., 2015). These experiments demonstrate that 
NGF can directly affect β-cell survival and function, leading to renewed interest in the 
possible pharmacological use of NGF. However there is little insight into the in vivo 
regulation of neurotrophins or the mechanisms through which they function in islets. Our 
work provides the first in vivo evidence for acute regulation of neurotrophin signaling in 
GSIS in the adult pancreas. In contrast to previous models suggesting autocrine NGF 
signaling within pancreatic β-cells, we demonstrate that NGF coming from the vasculature 
is acutely released to regulate actin remodeling and insulin secretion.  
 Both the discovery that NGF is supplied by the pancreatic vasculature and that 
circulating levels can be increased in response to glucose will be of importance for 
developing NGF therapies to improve β-cell function. In support of this notion, we found 
that TrkA is acutely phosphorylated in human islets and exogenous NGF was capable of 
increasing GSIS in vitro. Future studies determining how NGF expression and secretion 
are regulated in smooth muscle contractile cells will informative in deciphering how 
neurotrophins function differently during development and adulthood. As discussed in 
Chapter 4, changes in levels of NGF have been associated with several metabolic disorders 
(Manni et al., 2005, Civelek et al., 2013, Bullo et al., 2007), and may play an additional 
role in hyper-activation of the pituitary-adrenocortical axis (Otten et al., 1979) which could 
exacerbate hormonal imbalance leading to impaired glucose homeostasis. There are 
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additional parallels between stress-induced increases in NGF (Taglialatela et al., 1991) and 
stress related susceptibility to diabetes (Hilliard et al., 2016), which may indicate a 
desensitization of neurotrophin regulation of GSIS. Our results obtained from pre-diabetic 
human islets showed reduced activation of TrkA in response to glucose and failure to 
respond to NGF by potentiating insulin secretion in high glucose conditions. These findings 
support the idea that NGF/TrkA signaling may be an important pathway to target for 
metabolic screening and the development of pharmaceutical therapies. 
 Beyond the obvious therapeutic applications of this research to diabetes, regulation 
of NGF levels may be relevant to other conditions often associated with diabetes such as 
kidney disease and hypertension. Diabetes and hypertension are often associated and 
frequently occur together (Tuttle et al., 2014, Cheung and Li, 2012), and elevated glucose 
is known to activate the sympathetic nervous system resulting in increased blood pressure 
(Rowe et al., 1981). Intriguingly, vascular smooth muscle cells from hypertensive rats have 
increased NGF secretion (Donohue et al., 1989, Spitsbergen et al., 1995). Thus, it is 
tempting to speculate that the initial increase in circulating NGF reported in individuals 
during early stages of metabolic syndrome and diabetes (Chaldakov et al., 2003, Azar et 
al., 1999) may reflect a compensatory mechanism for improving insulin secretion in the 
face of increased metabolic demand. Indeed, contractile stimuli including arginine, 
vasopressin, angiotensin II, and norepinephrine can stimulate NGF secretion from smooth 
muscle cells (Tuttle et al., 1993, Creedon and Tuttle, 1991). In this way, alterations in NGF 
levels may be prognostic of a susceptibility to develop certain complications associated 




 Figure 7. Neurotrophin signaling acutely promotes glucose-induced insulin 
secretion via actin reorganization in -cells 
(1) NGF is secreted by pancreatic vascular smooth muscle cells and intra-islet pericytes in 
response to elevated glucose. (2) Vascular-derived NGF activates TrkA receptors on islet 
β-cells. (3) TrkA phosphorylation on Y794 leads to association and activation of the 
downstream effector, PLCγ, which triggers receptor internalization. (4) Endosomal 
signaling from internalized TrkA receptors recruits and activates the actin modulatory 
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